Link to all CCASAnet Publications in PubMed
2775998
A8CVXGYW
2023
items
1
0
date
desc
year
https://www.iedea.org/wp-content/plugins/zotpress/
2775998
A8CVXGYW
2022
items
1
0
date
desc
year
https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22instance%22%3A%22zotpress-2880d770ff5f26ace6bb90b09fe537f4%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228DAF46Y6%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A11361152%2C%22username%22%3A%22allison_scarlotta%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fallison_scarlotta%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20Ellen%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAjeh%2C%20Rogers%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMaruri%2C%20Fernanda%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusick%2C%20Beverly%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFreeman%2C%20Aimee%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Service%20delivery%20challenges%20in%20HIV%20care%20during%20the%20first%20year%20of%20the%20COVID-19%20pandemic%3A%20results%20from%20a%20site%20assessment%20survey%20across%20the%20global%20IeDEA%20consortium.%20%3Ci%3EJournal%20of%20the%20International%20AIDS%20Society%3C%5C%2Fi%3E%2C%20%3Ci%3E25%3C%5C%2Fi%3E%20%2812%29%2C%20S.%20e26036.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26036%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26036%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Service%20delivery%20challenges%20in%20HIV%20care%20during%20the%20first%20year%20of%20the%20COVID-19%20pandemic%3A%20results%20from%20a%20site%20assessment%20survey%20across%20the%20global%20IeDEA%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rogers%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Man-Po%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinei%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree%20Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelline%22%2C%22lastName%22%3A%22d%27Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Tanser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eug%5Cu00e8ne%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Interruptions%20in%20treatment%20pose%20risks%20for%20people%20with%20HIV%20%28PWH%29%20and%20threaten%20progress%20in%20ending%20the%20HIV%20epidemic%3B%20however%2C%20the%20COVID-19%20pandemic%27s%20impact%20on%20HIV%20service%20delivery%20across%20diverse%20settings%20is%20not%20broadly%20documented.%5CnMETHODS%3A%20From%20September%202020%20to%20March%202021%2C%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium%20surveyed%20238%20HIV%20care%20sites%20across%20seven%20geographic%20regions%20to%20document%20constraints%20in%20HIV%20service%20delivery%20during%20the%20first%20year%20of%20the%20pandemic%20and%20strategies%20for%20ensuring%20care%20continuity%20for%20PWH.%20Descriptive%20statistics%20were%20stratified%20by%20national%20HIV%20prevalence%20%28%3C1%25%2C%201-4.9%25%20and%20%5Cu22655%25%29%20and%20country%20income%20levels.%5CnRESULTS%3A%20Questions%20about%20pandemic-related%20consequences%20for%20HIV%20care%20were%20completed%20by%20225%20%2895%25%29%20sites%20in%2042%20countries%20with%20low%20%28n%20%3D%2082%29%2C%20medium%20%28n%20%3D%2086%29%20and%20high%20%28n%20%3D%2057%29%20HIV%20prevalence%2C%20including%20low-%20%28n%20%3D%2057%29%2C%20lower-middle%20%28n%20%3D%2079%29%2C%20upper-middle%20%28n%20%3D%2039%29%20and%20high-%20%28n%20%3D%2050%29%20income%20countries.%20Most%20sites%20reported%20being%20subject%20to%20pandemic-related%20restrictions%20on%20travel%2C%20service%20provision%20or%20other%20operations%20%2875%25%29%2C%20and%20experiencing%20negative%20impacts%20%2876%25%29%20on%20clinic%20operations%2C%20including%20decreased%20hours%5C%2Fdays%2C%20reduced%20provider%20availability%2C%20clinic%20reconfiguration%20for%20COVID-19%20services%2C%20record-keeping%20interruptions%20and%20suspension%20of%20partner%20support.%20Almost%20all%20sites%20in%20low-prevalence%20and%20high-income%20countries%20reported%20increased%20use%20of%20telemedicine%20%2885%25%20and%20100%25%2C%20respectively%29%2C%20compared%20with%20less%20than%20half%20of%20sites%20in%20high-prevalence%20and%20lower-income%20settings.%20Few%20sites%20in%20high-prevalence%20settings%20%282%25%29%20reported%20suspending%20antiretroviral%20therapy%20%28ART%29%20clinic%20services%2C%20and%20many%20reported%20adopting%20mitigation%20strategies%20to%20support%20adherence%2C%20including%20multi-month%20dispensing%20of%20ART%20%2895%25%29%20and%20designating%20community%20ART%20pick-up%20points%20%2844%25%29.%20While%20few%20sites%20%285%25%29%20reported%20stockouts%20of%20first-line%20ART%20regimens%2C%2010-11%25%20reported%20stockouts%20of%20second-%20and%20third-line%20regimens%2C%20respectively%2C%20primarily%20in%20high-prevalence%20and%20lower-income%20settings.%20Interruptions%20in%20HIV%20viral%20load%20%28VL%29%20testing%20included%20suspension%20of%20testing%20%2822%25%29%2C%20longer%20turnaround%20times%20%2841%25%29%20and%20supply%5C%2Freagent%20stockouts%20%2822%25%29%2C%20but%20did%20not%20differ%20across%20settings.%5CnCONCLUSIONS%3A%20While%20many%20sites%20in%20high%20HIV%20prevalence%20settings%20and%20lower-income%20countries%20reported%20introducing%20or%20expanding%20measures%20to%20support%20treatment%20adherence%20and%20continuity%20of%20care%2C%20the%20COVID-19%20pandemic%20resulted%20in%20disruptions%20to%20VL%20testing%20and%20ART%20supply%20chains%20that%20may%20negatively%20affect%20the%20quality%20of%20HIV%20care%20in%20these%20settings.%22%2C%22date%22%3A%222022-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26036%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22FK7XQRJZ%22%2C%22788L2TRF%22%2C%22GXCKG69T%22%2C%22723DEGN3%22%2C%22NYK75KNC%22%2C%22KP8858VX%22%2C%22QDTF783W%22%2C%229CN8YLIR%22%5D%2C%22dateModified%22%3A%222023-08-12T13%3A16%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22EQFZHBV8%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sobral%20et%20al.%22%2C%22parsedDate%22%3A%222022-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESobral%2C%20Luciana%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EArriaga%2C%20Mar%26%23xED%3Ba%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESouza%2C%20Alexandra%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBarreto-Duarte%2C%20Beatriz%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Determinants%20of%20losses%20in%20the%20tuberculosis%20infection%20cascade%20of%20care%20among%20children%20and%20adolescent%20contacts%20of%20pulmonary%20tuberculosis%20cases%3A%20A%20Brazilian%20multi-centre%20longitudinal%20study.%20%3Ci%3ELancet%20Regional%20Health.%20Americas%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%2C%20S.%20100358.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2022.100358%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2022.100358%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Determinants%20of%20losses%20in%20the%20tuberculosis%20infection%20cascade%20of%20care%20among%20children%20and%20adolescent%20contacts%20of%20pulmonary%20tuberculosis%20cases%3A%20A%20Brazilian%20multi-centre%20longitudinal%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luciana%22%2C%22lastName%22%3A%22Sobral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caio%22%2C%22lastName%22%3A%22Sales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aline%22%2C%22lastName%22%3A%22Benjamin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamile%20G.%22%2C%22lastName%22%3A%22de%20Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20Cristina%22%2C%22lastName%22%3A%22Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20R.%22%2C%22lastName%22%3A%22Lapa-E-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Approximately%2010%25%20of%20the%20global%20tuberculosis%20%28TB%29%20burden%20is%20in%20children.%20Identification%2C%20diagnosis%2C%20and%20early%20treatment%20of%20Mycobacterium%20tuberculosis%20infection%20%28TBI%29%20is%20critical%20to%20prevent%20progression%20to%20TB%20in%20children.%20The%20risk%20of%20TB%2C%20including%20severe%20disease%2C%20is%20highest%20in%20children%20%3C5%20years%20old.%20We%20evaluated%20the%20cascade%20of%20TBI%20care%20among%20child%20and%20adolescent%20TB%20contacts%20to%20identify%20factors%20associated%20with%20losses%20in%20the%20cascade.%5CnMETHODS%3A%20Close%20contacts%20%5Cu2264%2018%20years%20old%20of%20pulmonary%20TB%20patients%20enrolled%20between%202015%20and%202019%20in%20a%20multi-centre%20Brazilian%20cohort%20were%20followed%20for%20up%20to%2024%20months%20and%20classified%20according%20to%20age%20groups%3A%20%3C5%20years%2C%205-9%20years%2C%2010-14%20years%20and%2015-18%20years.%20Data%20on%20clinical%20investigation%2C%20radiographic%20examination%2C%20IGRA%20testing%20at%20baseline%20and%206%20months%2C%20initiation%20and%20completion%20of%20TB%20preventive%20treatment%20%28TPT%29%20were%20collected.%20Multivariable%20regression%20analyses%20identified%20factors%20associated%20with%20TBI%20and%20losses%20in%20the%20cascade%20of%20care%20in%20children%20and%20adolescents.%5CnFINDINGS%3A%20Among%201795%20TB%20contacts%20initially%20identified%2C%20530%20%2829%5Cu00b75%25%29%20were%20%5Cu226418%20years%20old.%20Losses%20for%20all%20steps%20in%20the%20cascade%20were%20especially%20high%20in%20children%20%3C5%20years%20old%20%2888%25%29%20because%20at%20this%20age%20all%20contacts%20are%20recommended%20to%20initiate%20TPT.%20As%20a%20proportion%20of%20all%20children%2C%20completion%20of%20TPT%20was%20low%20%28between%2010%25%20and%2013%25%29%20in%20all%20age-groups.%20Furthermore%2C%20multivariable%20regression%20revealed%20that%20younger%20age%20of%20contacts%20and%20TB%20index%20cases%20who%20were%20female%2C%20had%20pulmonary%20cavities%2C%20and%20persistent%20cough%20were%20independently%20associated%20with%20losses%20in%20the%20cascade%20of%20care%20among%20persons%20%5Cu226418%20years%20old.%5CnINTERPRETATION%3A%20Losses%20in%20the%20TBI%20cascade%20were%20the%20highest%20among%20children%20%3C5%20years%2C%20which%20was%20the%20group%20at%20highest%20risk%20for%20TB%20among%20the%20four%20age%20groups.%20The%20findings%20highlight%20the%20need%20to%20improve%20screening%2C%20initiation%2C%20and%20completion%20of%20TPT%20of%20young%20children%20who%20are%20close%20contacts%20of%20people%20with%20TB%20in%20Brazil.%5CnFUNDING%3A%20National%20Institutes%20of%20Allergy%20and%20Infectious%20Diseases.%22%2C%22date%22%3A%222022-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2022.100358%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22GXCKG69T%22%5D%2C%22dateModified%22%3A%222023-03-16T16%3A32%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22ZHUBVZYA%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A11361152%2C%22username%22%3A%22allison_scarlotta%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fallison_scarlotta%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Lewis%20et%20al.%22%2C%22parsedDate%22%3A%222022-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ELewis%2C%20Judith%20T.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EStephens%2C%20Jeremy%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusick%2C%20Beverly%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrown%2C%20Steven%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMalateste%2C%20Karen%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20The%20IeDEA%20harmonist%20data%20toolkit%3A%20A%20data%20quality%20and%20data%20sharing%20solution%20for%20a%20global%20HIV%20research%20consortium.%20%3Ci%3EJournal%20of%20Biomedical%20Informatics%3C%5C%2Fi%3E%2C%20%3Ci%3E131%3C%5C%2Fi%3E%2C%20S.%20104110.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbi.2022.104110%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbi.2022.104110%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20IeDEA%20harmonist%20data%20toolkit%3A%20A%20data%20quality%20and%20data%20sharing%20solution%20for%20a%20global%20HIV%20research%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%20T.%22%2C%22lastName%22%3A%22Lewis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Stephens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cam%22%2C%22lastName%22%3A%22Ha%20Dao%20Ostinelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiuhu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenna%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22on%20the%20behalf%20of%20leDEA%22%7D%5D%2C%22abstractNote%22%3A%22We%20describe%20the%20design%2C%20implementation%2C%20and%20impact%20of%20a%20data%20harmonization%2C%20data%20quality%20checking%2C%20and%20dynamic%20report%20generation%20application%20in%20an%20international%20observational%20HIV%20research%20network.%20The%20IeDEA%20Harmonist%20Data%20Toolkit%20is%20a%20web-based%20application%20written%20in%20the%20open%20source%20programming%20language%20R%2C%20employs%20the%20R%5C%2FShiny%20and%20RMarkdown%20packages%2C%20and%20leverages%20the%20REDCap%20data%20collection%20platform%20for%20data%20model%20definition%20and%20user%20authentication.%20The%20Toolkit%20performs%20data%20quality%20checks%20on%20uploaded%20datasets%2C%20checks%20for%20conformance%20with%20the%20network%27s%20common%20data%20model%2C%20displays%20the%20results%20both%20interactively%20and%20in%20downloadable%20reports%2C%20and%20stores%20approved%20datasets%20in%20secure%20cloud%20storage%20for%20retrieval%20by%20the%20requesting%20investigator.%20Including%20stakeholders%20and%20users%20in%20the%20design%20process%20was%20key%20to%20the%20successful%20adoption%20of%20the%20application.%20A%20survey%20of%20regional%20data%20managers%20as%20well%20as%20initial%20usage%20metrics%20indicate%20that%20the%20Toolkit%20saves%20time%20and%20results%20in%20improved%20data%20quality%2C%20with%20a%2061%25%20mean%20reduction%20in%20the%20number%20of%20error%20records%20in%20a%20dataset.%20The%20generalized%20application%20design%20allows%20the%20Toolkit%20to%20be%20easily%20adapted%20to%20other%20research%20networks.%22%2C%22date%22%3A%222022-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbi.2022.104110%22%2C%22ISSN%22%3A%221532-0480%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22FK7XQRJZ%22%2C%22788L2TRF%22%2C%22723DEGN3%22%2C%22NYK75KNC%22%2C%22KP8858VX%22%2C%22QDTF783W%22%2C%229CN8YLIR%22%5D%2C%22dateModified%22%3A%222023-08-12T13%3A17%3A36Z%22%7D%7D%2C%7B%22key%22%3A%222I5FJSZB%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Crabtree-Ramirez%20et%20al.%22%2C%22parsedDate%22%3A%222022-04-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECrabtree-Ramirez%2C%20Brenda%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJenkins%2C%20Cathy%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EShepherd%2C%20Bryan%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJayathilake%2C%20Karu%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EVeloso%2C%20Valdilea%20G.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Tuberculosis%20treatment%20intermittency%20in%20the%20continuation%20phase%20and%20mortality%20in%20HIV-positive%20persons%20receiving%20antiretroviral%20therapy.%20%3Ci%3EBMC%20Infectious%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E22%3C%5C%2Fi%3E%20%281%29%2C%20S.%20341.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12879-022-07330-5%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12879-022-07330-5%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20treatment%20intermittency%20in%20the%20continuation%20phase%20and%20mortality%20in%20HIV-positive%20persons%20receiving%20antiretroviral%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serena%22%2C%22lastName%22%3A%22Koenig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CCASAnet%20Region%20of%20IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Some%20tuberculosis%20%28TB%29%20treatment%20guidelines%20recommend%20daily%20TB%20treatment%20in%20both%20the%20intensive%20and%20continuation%20phases%20of%20treatment%20in%20HIV-positive%20persons%20to%20decrease%20the%20risk%20of%20relapse%20and%20acquired%20drug%20resistance.%20However%2C%20guidelines%20vary%20across%20countries%2C%20and%20treatment%20is%20given%207%2C%205%2C%203%2C%20or%202%5Cu00a0days%5C%2Fweek.%20The%20effect%20of%20TB%20treatment%20intermittency%20in%20the%20continuation%20phase%20on%20mortality%20in%20HIV-positive%20persons%20on%20antiretroviral%20therapy%20%28ART%29%2C%20is%20not%20well-described.%5CnMETHODS%3A%20We%20conducted%20an%20observational%20cohort%20study%20among%20HIV-positive%20adults%20treated%20for%20TB%20between%202000%20and%202018%20and%20after%20enrollment%20into%20the%20Caribbean%2C%20Central%2C%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%3B%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%20and%20Peru%29.%20All%20received%20standard%20TB%20therapy%20%282-month%20initiation%20phase%20of%20daily%20isoniazid%2C%20rifampin%20or%20rifabutin%2C%20pyrazinamide%5Cu2009%5Cu00b1%5Cu2009ethambutol%29%20and%20continuation%20phase%20of%20isoniazid%20and%20rifampin%20or%20rifabutin%2C%20administered%20concomitantly%20with%20ART.%20Known%20timing%20of%20ART%20and%20TB%20treatment%20were%20also%20inclusion%20criteria.%20Kaplan-Meier%20and%20Cox%20proportional%20hazards%20methods%20compared%20time%20to%20death%20between%20groups.%20Missing%20model%20covariates%20were%20imputed%20via%20multiple%20imputation.%5CnRESULTS%3A%202303%20patients%20met%20inclusion%20criteria%3A%202003%2887%25%29%20received%20TB%20treatment%205-7%5Cu00a0days%5C%2Fweek%20and%20300%2813%25%29%202-3%5Cu00a0days%5C%2Fweek%20in%20the%20continuation%20phase.%20Intermittency%20varied%20by%20site%3A%20100%25%20of%20patients%20from%20Brazil%20and%20Haiti%20received%20continuation%20phase%20treatment%205-7%5Cu00a0days%5C%2Fweek%2C%20followed%20by%20Honduras%20%2891%25%29%2C%20Peru%20%2842%25%29%2C%20Mexico%20%287%25%29%2C%20and%20Chile%20%280%25%29.%20The%20crude%20risk%20of%20death%20was%20lower%20among%20those%20receiving%20treatment%205-7%20vs.%202-3%5Cu00a0days%5C%2Fweek%20%28HR%5Cu2009%3D%5Cu20090.68%3B%2095%25%20CI%5Cu2009%3D%5Cu20090.51-0.91%3B%20P%5Cu2009%3D%5Cu20090.008%29.%20After%20adjusting%20for%20age%2C%20sex%2C%20CD4%2C%20ART%20use%20at%20TB%20diagnosis%2C%20site%20of%20TB%20disease%20%28pulmonary%20vs.%20extrapulmonary%29%2C%20and%20year%20of%20TB%20diagnosis%2C%20mortality%20risk%20was%20lower%2C%20but%20not%20significantly%2C%20among%20those%20treated%205-7%5Cu00a0days%5C%2Fweek%20vs.%202-3%5Cu00a0days%5C%2Fweek%20%28HR%200.75%2C%2095%25CI%200.55-1.01%3B%20P%5Cu2009%3D%5Cu20090.06%29.%20After%20also%20stratifying%20by%20study%20site%2C%20there%20was%20no%20longer%20a%20protective%20effect%20%28HR%201.42%2C%2095%25CI%200.83-2.45%3B%20P%5Cu2009%3D%5Cu20090.20%29.%5CnCONCLUSIONS%3A%20TB%20treatment%205-7%5Cu00a0days%5C%2Fweek%20was%20associated%20with%20a%20marginally%20decreased%20risk%20of%20death%20compared%20to%20TB%20treatment%202-3%5Cu00a0days%5C%2Fweek%20in%20the%20continuation%20phase%20in%20multivariable%2C%20unstratified%20analyses.%20However%2C%20little%20variation%20in%20TB%20treatment%20intermittency%20within%20country%20meant%20the%20results%20could%20have%20been%20driven%20by%20other%20differences%20between%20study%20sites.%20Therefore%2C%20randomized%20trials%20are%20needed%2C%20especially%20in%20heterogenous%20regions%20such%20as%20Latin%20America.%22%2C%22date%22%3A%222022-04-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12879-022-07330-5%22%2C%22ISSN%22%3A%221471-2334%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22GXCKG69T%22%5D%2C%22dateModified%22%3A%222022-04-11T12%3A35%3A14Z%22%7D%7D%2C%7B%22key%22%3A%222VGZMGCE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A11361152%2C%22username%22%3A%22allison_scarlotta%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fallison_scarlotta%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Justice%20et%20al.%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJustice%2C%20Amy%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EGoetz%2C%20Matthew%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EStewart%2C%20Cameron%20N.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHogan%2C%20Brenna%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHumes%2C%20Elizabeth%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Delayed%20presentation%20of%20HIV%20among%20older%20individuals%3A%20a%20growing%20problem.%20%3Ci%3EThe%20Lancet.%20HIV%3C%5C%2Fi%3E%2C%20%3Ci%3E9%3C%5C%2Fi%3E%20%284%29%2C%20S.%20e269%26%23x2013%3Be280.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3018%2822%2900003-0%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3018%2822%2900003-0%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Delayed%20presentation%20of%20HIV%20among%20older%20individuals%3A%20a%20growing%20problem%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20C.%22%2C%22lastName%22%3A%22Justice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20B.%22%2C%22lastName%22%3A%22Goetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%20N.%22%2C%22lastName%22%3A%22Stewart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenna%20C.%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Humes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinei%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reena%22%2C%22lastName%22%3A%22Rajasuriar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Awachana%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%5D%2C%22abstractNote%22%3A%22Late%20presentation%20for%20care%20is%20a%20major%20impediment%20to%20the%20prevention%20and%20effective%20treatment%20of%20HIV%20infection.%20Older%20individuals%20are%20at%20increased%20risk%20of%20late%20presentation%2C%20represent%20a%20growing%20proportion%20of%20people%20with%20late%20presentation%2C%20and%20might%20require%20interventions%20tailored%20to%20their%20age%20group.%20We%20provide%20a%20summary%20of%20the%20literature%20published%20globally%20between%202016-21%20%28reporting%20data%20from%201984-2018%29%20and%20quantify%20the%20association%20of%20age%20with%20delayed%20presentation.%20Using%20the%20most%20common%20definitions%20of%20late%20presentation%20and%20older%20age%20from%20these%20earlier%20studies%2C%20we%20update%20this%20work%20with%20data%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%2C%20focusing%20on%20data%20from%202000-19%2C%20encompassing%20four%20continents.%20Finally%2C%20we%20consider%20how%20late%20presentation%20among%20older%20individuals%20might%20be%20more%20effectively%20addressed%20as%20electronic%20medical%20records%20become%20widely%20adopted.%22%2C%22date%22%3A%222022-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2822%2900003-0%22%2C%22ISSN%22%3A%222352-3018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22FK7XQRJZ%22%2C%22788L2TRF%22%2C%22GXCKG69T%22%2C%22723DEGN3%22%2C%22NYK75KNC%22%2C%22KP8858VX%22%2C%22QDTF783W%22%2C%229CN8YLIR%22%5D%2C%22dateModified%22%3A%222023-08-13T13%3A00%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22HBXKMEXB%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A11361152%2C%22username%22%3A%22allison_scarlotta%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fallison_scarlotta%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Antimycobacterial%20Susceptibility%20Testing%20Group%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAntimycobacterial%20Susceptibility%20Testing%20Group%3C%5C%2Fspan%3E%20%282022%29.%20Updating%20the%20approaches%20to%20define%20susceptibility%20and%20resistance%20to%20anti-tuberculosis%20agents%3A%20implications%20for%20diagnosis%20and%20treatment.%20%3Ci%3EThe%20European%20Respiratory%20Journal%3C%5C%2Fi%3E%2C%20%3Ci%3E59%3C%5C%2Fi%3E%20%284%29%2C%20S.%202200166.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00166-2022%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00166-2022%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Updating%20the%20approaches%20to%20define%20susceptibility%20and%20resistance%20to%20anti-tuberculosis%20agents%3A%20implications%20for%20diagnosis%20and%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Antimycobacterial%20Susceptibility%20Testing%20Group%22%7D%5D%2C%22abstractNote%22%3A%22Inappropriately%20high%20breakpoints%20have%20resulted%20in%20systematic%20false-susceptible%20AST%20results%20to%20anti-TB%20drugs.%20MIC%2C%20PK%5C%2FPD%20and%20clinical%20outcome%20data%20should%20be%20combined%20when%20setting%20breakpoints%20to%20minimise%20the%20emergence%20and%20spread%20of%20antimicrobial%20resistance.%20https%3A%5C%2F%5C%2Fbit.ly%5C%2F3i43wb6%22%2C%22date%22%3A%222022-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.00166-2022%22%2C%22ISSN%22%3A%221399-3003%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22FK7XQRJZ%22%2C%22788L2TRF%22%2C%22GXCKG69T%22%2C%22723DEGN3%22%2C%22NYK75KNC%22%2C%22KP8858VX%22%2C%22QDTF783W%22%2C%229CN8YLIR%22%5D%2C%22dateModified%22%3A%222023-08-12T13%3A17%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22KBSBMLGG%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coelho%20et%20al.%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECoelho%2C%20Lara%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJenkins%2C%20Cathy%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EShepherd%2C%20Bryan%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EPape%2C%20Jean%20W.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMejia%20Cordero%2C%20Fernando%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Weight%20gain%20post-ART%20in%20HIV%2B%20Latinos%5C%2Fas%20differs%20in%20the%20USA%2C%20Haiti%2C%20and%20Latin%20America.%20%3Ci%3ELancet%20Regional%20Health.%20Americas%3C%5C%2Fi%3E%2C%20%3Ci%3E8%3C%5C%2Fi%3E%2C%20S.%20100173.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2021.100173%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2021.100173%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Weight%20gain%20post-ART%20in%20HIV%2B%20Latinos%5C%2Fas%20differs%20in%20the%20USA%2C%20Haiti%2C%20and%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mejia%20Cordero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree%20Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20R.%22%2C%22lastName%22%3A%22Koethe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%20C.%22%2C%22lastName%22%3A%22Marconi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phyllis%20C.%22%2C%22lastName%22%3A%22Tien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20L.%22%2C%22lastName%22%3A%22Willig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Colasanti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%20M.%22%2C%22lastName%22%3A%22Crane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20John%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Horberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Mayor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Silverberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20An%20obesity%20epidemic%20has%20been%20documented%20among%20adult%20Latinos%5C%2Fas%20in%20Latin%20America%20and%20the%20United%20States%20%28US%29%3B%20however%2C%20little%20is%20known%20about%20obesity%20among%20Latinos%5C%2Fas%20with%20HIV%20%28PWH%29.%20Moreover%2C%20Latinos%5C%2Fas%20PWH%20in%20the%20US%20may%20have%20different%20weight%20trajectories%20than%20those%20in%20Latin%20America%20due%20to%20the%20cultural%20and%20environmental%20contexts.%20We%20assessed%20weight%20and%20body%20mass%20index%20%28BMI%29%20trajectories%20among%20PWH%20initiating%20antiretroviral%20therapy%20%28ART%29%20across%205%20countries%20in%20Latin%20America%20and%20the%20Caribbean%20and%20the%20US.%5CnMethods%3A%20ART-na%5Cu00ffve%20PWH%20%5Cu226518%20years%20old%2C%20enrolled%20in%20Brazil%2C%20Honduras%2C%20Mexico%2C%20Peru%2C%20and%20Haiti%20%28sites%20within%20CCA-SAnet%29%20and%20the%20US%20%28NA-ACCORD%29%20starting%20ART%20between%202000%20and%202017%2C%20with%20at%20least%20one%20weight%20measured%20after%20ART%20initiation%20were%20included.%20Participants%20were%20classified%20according%20to%20site%5C%2Fethnicity%20as%3A%20Latinos%5C%2Fas%20in%20US%2C%20non-Latinos%5C%2Fas%20in%20US%2C%20Haitians%2C%20and%20Latinos%5C%2Fas%20in%20Latin%20America.%20Generalized%20least%20squares%20models%20were%20used%20to%20assess%20trends%20in%20weight%20and%20BMI.%20Models%20estimating%20probabilities%20of%20becoming%20overweight%5C%2Fobese%20%28BMI%20%5Cu226525%20kg%5C%2Fm2%29%20and%20of%20becoming%20obese%20%28BMI%20%5Cu226530%20kg%5C%2Fm2%29%20post%20ART%20initiation%20for%20males%20and%20females%20were%20fit%20using%20generalized%20estimating%20equations%20with%20a%20logit%20link%20and%20an%20independence%20working%20correlation%20structure.%5CnFindings%3A%20Among%2059%2C207%20PWH%2C%209%25%20were%20Latinos%5C%2Fas%20from%20Latin%20America%2C%209%25%20Latinos%5C%2Fas%20from%20the%20US%2C%2068%25%20non-Latinos%5C%2Fas%20from%20the%20US%20and%2014%25%20were%20Haitian.%20At%20ART%20initiation%2C%2029%25%20were%20overweight%20and%2014%25%20were%20obese.%20Post-ART%20weight%20and%20BMI%20increases%20were%20steeper%20for%20Latinos%5C%2Fas%20in%20Latin%20America%20compared%20with%20other%20sites%5C%2Fethnicities%3B%20however%2C%20BMI%20at%203-years%20post%20ART%20remained%20lower%20compared%20to%20Latinos%5C%2Fas%20and%20non-Latinos%5C%2Fas%20in%20the%20US.%20Among%20females%2C%20at%203-years%20post%20ART%20initiation%20the%20greatest%20adjusted%20probability%20of%20obesity%20was%20found%20among%20non-Latinas%20in%20the%20US%20%2815%5Cu00b72%25%29%20and%20lowest%20among%20Latinas%20in%20Latin%20America%20%288.6%25%29.%20Among%20males%2C%20while%20starting%20with%20a%20lower%20BMI%2C%20Latinos%20in%20Latin%20America%20had%20the%20greatest%20adjusted%20probability%20of%20becoming%20overweight%20or%20obese%203-years%20post-ART%20initiation.%5CnInterpretation%3A%20In%20the%20Americas%2C%20PWH%20gain%20substantial%20weight%20after%20ART%20initiation.%20Despite%20environmental%20and%20cultural%20differences%2C%20PWH%20in%20Latin%20America%2C%20Haiti%20and%20Latinos%20and%20non-Latinos%20in%20the%20US%20share%20similar%20BMI%20trajectories%20on%20ART%20and%20high%20probabilities%20of%20becoming%20overweight%20and%20obese%20over%20time.%20Multicohort%20studies%20are%20needed%20to%20better%20understand%20the%20burden%20of%20other%20metabolic%20syndrome%20components%20in%20PWH%20across%20different%20countries.%22%2C%22date%22%3A%222022-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2021.100173%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22FK7XQRJZ%22%2C%22GXCKG69T%22%2C%229CN8YLIR%22%5D%2C%22dateModified%22%3A%222022-11-11T09%3A56%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22MIII9MKM%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Caro-Vega%20et%20al.%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECaro-Vega%2C%20Yanink%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERebeiro%2C%20Peter%20F.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EShepherd%2C%20Bryan%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBelaunzar%26%23xE1%3Bn-Zamudio%2C%20Pablo%20F.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECrabtree-Ramirez%2C%20Brenda%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Clinical%20effects%20of%20durability%20of%20immunosuppression%20in%20virologically%20suppressed%20ART-initiating%20persons%20with%20HIV%20in%20Latin%20America.%20A%20retrospective%20cohort%20study.%20%3Ci%3ELancet%20Regional%20Health.%20Americas%3C%5C%2Fi%3E%2C%20%3Ci%3E8%3C%5C%2Fi%3E%2C%20S.%20100175.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2021.100175%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2021.100175%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20effects%20of%20durability%20of%20immunosuppression%20in%20virologically%20suppressed%20ART-initiating%20persons%20with%20HIV%20in%20Latin%20America.%20A%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20Mendes%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Clinical%20outcomes%20are%20rarely%20studied%20in%20virologically%20suppressed%20people%20living%20with%20HIV%20%28PWH%29%20and%20incomplete%20CD4%20recovery.%20To%20explore%20whether%20time%20living%20with%20severe%20immunosuppression%20predict%20clinical%20outcomes%20better%20than%20baseline%20or%20time%20updated%20CD4%2C%20we%20estimated%20the%20association%20between%20cumulative%20percentage%20of%20time%20with%20CD4%20%3C200%20cells%5C%2F%5Cu03bcL%20during%20viral%20suppression%20%28VS%29%20%28%25tCD4%3C200%29%2C%20and%20mortality%20and%20comorbidities%20during%202000-2019.%5CnMethods%3A%20In%20a%20retrospective%20cohort%20analysis%2C%20we%20followed%20PWH%20initiating%20ART%20in%20Latin%20America%20from%20first%20VS%20%28HIV-RNA%3C200%20copies%5C%2F%5Cu03bcL%29%20to%20death%2C%20virological%20failure%20or%20loss%20to%20follow-up.%20We%20fit%20Cox%20models%20to%20estimate%20risk%20of%20death%20and%5C%2For%20AIDS-defining%20and%20serious%20non-AIDS-defining%20events%20%28ADE%20and%20SNADE%20-cancer%2C%20cardiovascular%2C%20liver%2C%20and%20renal%20diseases%29%20by%20%25tCD4%3C200%20%28continuous%20variable%29.%20We%20predicted%20survival%20probabilities%20for%20each%20event%20and%20calculated%20risks%20of%20hypothetical%20cases%20of%20different%20%25tCD4%3C200.%5CnFindings%3A%20In%208%2C369%20patients%20with%2034%5Cu00b79%20months%20of%20follow-up%20%28median%2C%20IQR%3A%2016%5Cu00b77%2C%2069%5Cu00b71%29%2C%204%2C274%20%2851%25%29%20started%20ART%20with%20CD4%3C200%20cells%5C%2F%5Cu03bcL.%20Median%20%25tCD4%3C200%20was%200%25%20%28IQR%3A%200%2C%2015%25%29.%20We%20identified%20195%20%282%5Cu00b73%25%29%20deaths%20and%20584%20%287%5Cu00b72%25%29%20patients%20with%20ADE%5C%2FSNADE.%20For%20an%20increased%20%25tCD4%3C200%20of%2015%25%20%28e.g.%2C%2015%25%20vs.%200%25%29%2C%20the%20adjusted%20relative%20hazard%20%28aHR%29%20of%20death%20was%201%5Cu00b727%20%2895%25%20confidence%20interval%20%5BCI%5D%3A%201%5Cu00b719%20-%201%5Cu00b735%29%2C%20of%20ADE%5C%2FSNADE%20was%201%5Cu00b713%20%2895%25CI%3A%201%5Cu00b709%20-%201%5Cu00b717%29%2C%20of%20SNADE%20was%200%5Cu00b796%20%2895%25CI%3A%200%5Cu00b789%20-%201%5Cu00b702%29%20and%20of%20death%5C%2FADE%5C%2FSNADE%20was%201%5Cu00b711%20%2895%25CI%3A%201%5Cu00b707%20-%201%5Cu00b714%29.%20Estimates%20were%20similar%20after%20adjusting%20for%20time%20updated%20CD4%20count.%5CnInterpretation%3A%20In%20virologically%20suppressed%20PWH%2C%20increased%20time%20living%20with%20severe%20immunosuppression%20had%20an%20increased%20risk%20of%20death%20and%20ADE%5C%2FSNADE%20in%20this%20Latin%20American%20cohort%2C%20independently%20of%20time%20updated%20CD4%20count.%5CnFunding%3A%20This%20work%20was%20supported%20by%20the%20NIH-funded%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%2C%20U01AI069923%29%2C%20a%20member%20cohort%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28leDEA%29.%20This%20award%20is%20funded%20by%20the%20following%20institutes%3A%20Eunice%20Kennedy%20Shriver%20National%20Institute%20Of%20Child%20Health%20%26%20Human%20Development%20%28NICHD%29%2C%20National%20Cancer%20Institute%20%28NCI%29%2C%20National%20Institute%20Of%20Allergy%20And%20Infectious%20Diseases%20%28NIAID%29%2C%20National%20Institute%20Of%20Mental%20Health%20%28NIMH%29%2C%20the%20National%20Heart%2C%20Lung%2C%20and%20Blood%20Institute%20%28NHLBI%29%2C%20the%20National%20Institute%20on%20Alcohol%20Abuse%20and%20Alcoholism%20%28NIAAA%29%2C%20the%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20%28NIDDK%29%2C%20and%20the%20Fogarty%20International%20Center%20%28FIC%29.%20Specific%20funding%20was%20provided%20from%20the%20Fogarty%20International%20Center%20%28FIC%29%20for%20lead%20author%2C%20Yanink%20Caro-Vega%2C%20for%20the%20Fogarty-IeDEA%20Mentorship%20Program%20%28FIMP%29.%22%2C%22date%22%3A%222022-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2021.100175%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22GXCKG69T%22%5D%2C%22dateModified%22%3A%222022-07-11T06%3A55%3A11Z%22%7D%7D%2C%7B%22key%22%3A%225KVT3AD5%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A11361152%2C%22username%22%3A%22allison_scarlotta%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fallison_scarlotta%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECollaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJesson%2C%20Julie%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECrichton%2C%20Siobhan%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EQuartagno%2C%20Matteo%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EYotebieng%2C%20Marcel%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Growth%20and%20CD4%20patterns%20of%20adolescents%20living%20with%20perinatally%20acquired%20HIV%20worldwide%2C%20a%20CIPHER%20cohort%20collaboration%20analysis.%20%3Ci%3EJournal%20of%20the%20International%20AIDS%20Society%3C%5C%2Fi%3E%2C%20%3Ci%3E25%3C%5C%2Fi%3E%20%283%29%2C%20S.%20e25871.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.25871%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.25871%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Growth%20and%20CD4%20patterns%20of%20adolescents%20living%20with%20perinatally%20acquired%20HIV%20worldwide%2C%20a%20CIPHER%20cohort%20collaboration%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Jesson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siobhan%22%2C%22lastName%22%3A%22Crichton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matteo%22%2C%22lastName%22%3A%22Quartagno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%20J.%22%2C%22lastName%22%3A%22Abrams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kulkanya%22%2C%22lastName%22%3A%22Chokephaibulkit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Le%20Coeur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Ak%5Cu00e9-Assi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kunjal%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Paul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jihane%22%2C%22lastName%22%3A%22Ben-Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%22%2C%22lastName%22%3A%22Van%20Dyke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Judd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lynne%22%2C%22lastName%22%3A%22Mofenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marissa%22%2C%22lastName%22%3A%22Vicari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Seage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda-Gail%22%2C%22lastName%22%3A%22Bekker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaffiq%22%2C%22lastName%22%3A%22Essajee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Gibb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Penazzato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Intira%20Jeannie%22%2C%22lastName%22%3A%22Collins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Slogrove%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Powis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paige%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mogomotsi%22%2C%22lastName%22%3A%22Matshaba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lineo%22%2C%22lastName%22%3A%22Thahane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phoebe%22%2C%22lastName%22%3A%22Nyasulu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhekumusa%22%2C%22lastName%22%3A%22Lukhele%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lumumba%22%2C%22lastName%22%3A%22Mwita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adeodata%22%2C%22lastName%22%3A%22Kekitiinwa-Rukyalekere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Wanless%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tessa%22%2C%22lastName%22%3A%22Goetghebuer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Thorne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josiane%22%2C%22lastName%22%3A%22Warszawski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luisa%22%2C%22lastName%22%3A%22Galli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annemarie%20M.%20C.%22%2C%22lastName%22%3A%22van%20Rossum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlo%22%2C%22lastName%22%3A%22Giaquinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Magdalena%22%2C%22lastName%22%3A%22Marczynska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Marques%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filipa%22%2C%22lastName%22%3A%22Prata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luminita%22%2C%22lastName%22%3A%22Ene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyuba%22%2C%22lastName%22%3A%22Okhonskaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marisa%22%2C%22lastName%22%3A%22Navarro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoinette%22%2C%22lastName%22%3A%22Frick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lars%22%2C%22lastName%22%3A%22Naver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Kahlert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alla%22%2C%22lastName%22%3A%22Volokha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Chappell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20William%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adias%22%2C%22lastName%22%3A%22Marcelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Apondi%22%2C%22lastName%22%3A%22Ogalo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%20Akoth%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josephine%22%2C%22lastName%22%3A%22Muhairwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannock%22%2C%22lastName%22%3A%22Tweya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariam%22%2C%22lastName%22%3A%22Sylla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marceline%22%2C%22lastName%22%3A%22D%27Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorna%22%2C%22lastName%22%3A%22Renner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Abzug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Oleske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murli%22%2C%22lastName%22%3A%22Purswani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chloe%22%2C%22lastName%22%3A%22Teasdale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harriet%22%2C%22lastName%22%3A%22Nuwagaba-Biribonwoha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%22%2C%22lastName%22%3A%22Goodall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Adolescents%20living%20with%20HIV%20are%20subject%20to%20multiple%20co-morbidities%2C%20including%20growth%20retardation%20and%20immunodeficiency.%20We%20describe%20growth%20and%20CD4%20evolution%20during%20adolescence%20using%20data%20from%20the%20Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20global%20project.%5CnMETHODS%3A%20Data%20were%20collected%20between%201994%20and%202015%20from%2011%20CIPHER%20networks%20worldwide.%20Adolescents%20with%20perinatally%20acquired%20HIV%20infection%20%28APH%29%20who%20initiated%20antiretroviral%20therapy%20%28ART%29%20before%20age%2010%20years%2C%20with%20at%20least%20one%20height%20or%20CD4%20count%20measurement%20while%20aged%2010-17%20years%2C%20were%20included.%20Growth%20was%20measured%20using%20height-for-age%20Z-scores%20%28HAZ%2C%20stunting%20if%20%3C-2%20SD%2C%20WHO%20growth%20charts%29.%20Linear%20mixed-effects%20models%20were%20used%20to%20study%20the%20evolution%20of%20each%20outcome%20between%20ages%2010%20and%2017.%20For%20growth%2C%20sex-specific%20models%20with%20fractional%20polynomials%20were%20used%20to%20model%20non-linear%20relationships%20for%20age%20at%20ART%20initiation%2C%20HAZ%20at%20age%2010%20and%20time%2C%20defined%20as%20current%20age%20from%2010%20to%2017%20years%20of%20age.%5CnRESULTS%3A%20A%20total%20of%2020%2C939%20and%2019%2C557%20APH%20were%20included%20for%20the%20growth%20and%20CD4%20analyses%2C%20respectively.%20Half%20were%20females%2C%20two-thirds%20lived%20in%20East%20and%20Southern%20Africa%2C%20and%20median%20age%20at%20ART%20initiation%20ranged%20from%20%3C3%20years%20in%20North%20America%20and%20Europe%20to%20%3E7%20years%20in%20sub-Saharan%20African%20regions.%20At%20age%2010%2C%20stunting%20ranged%20from%206%25%20in%20North%20America%20and%20Europe%20to%2039%25%20in%20the%20Asia-Pacific%3B%2019%25%20overall%20had%20CD4%20counts%20%3C500%20cells%5C%2Fmm3%20.%20Across%20adolescence%2C%20higher%20HAZ%20was%20observed%20in%20females%20and%20among%20those%20in%20high-income%20countries.%20APH%20with%20stunting%20at%20age%2010%20and%20those%20with%20late%20ART%20initiation%20%28after%20age%205%29%20had%20the%20largest%20HAZ%20gains%20during%20adolescence%2C%20but%20these%20gains%20were%20insufficient%20to%20catch-up%20with%20non-stunted%2C%20early%20ART-treated%20adolescents.%20From%20age%2010%20to%2016%20years%2C%20mean%20CD4%20counts%20declined%20from%20768%20to%20607%20cells%5C%2Fmm3%20.%20This%20decline%20was%20observed%20across%20all%20regions%2C%20in%20males%20and%20females.%5CnCONCLUSIONS%3A%20Growth%20patterns%20during%20adolescence%20differed%20substantially%20by%20sex%20and%20region%2C%20while%20CD4%20patterns%20were%20similar%2C%20with%20an%20observed%20CD4%20decline%20that%20needs%20further%20investigation.%20Early%20diagnosis%20and%20timely%20initiation%20of%20treatment%20in%20early%20childhood%20to%20prevent%20growth%20retardation%20and%20immunodeficiency%20are%20critical%20to%20improving%20APH%20growth%20and%20CD4%20outcomes%20by%20the%20time%20they%20reach%20adulthood.%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25871%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22788L2TRF%22%2C%22GXCKG69T%22%2C%22723DEGN3%22%2C%22NYK75KNC%22%2C%22KP8858VX%22%2C%22QDTF783W%22%2C%229CN8YLIR%22%5D%2C%22dateModified%22%3A%222023-08-13T13%3A02%3A57Z%22%7D%7D%2C%7B%22key%22%3A%2297U9Z7VN%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Romo%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERomo%2C%20Matthew%20L.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EPatel%2C%20Rena%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEdwards%2C%20Jessie%20K.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHumphrey%2C%20John%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusick%2C%20Beverly%20S.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Disparities%20in%20Dolutegravir%20Uptake%20Affecting%20Females%20of%20Reproductive%20Age%20With%20HIV%20in%20Low-%20and%20Middle-Income%20Countries%20After%20Initial%20Concerns%20About%20Teratogenicity%26%23x202F%3B%3A%20An%20Observational%20Study.%20%3Ci%3EAnnals%20of%20Internal%20Medicine%3C%5C%2Fi%3E%2C%20%3Ci%3E175%3C%5C%2Fi%3E%20%281%29%2C%20S.%2084%26%23x2013%3B94.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7326%5C%2FM21-3037%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7326%5C%2FM21-3037%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Disparities%20in%20Dolutegravir%20Uptake%20Affecting%20Females%20of%20Reproductive%20Age%20With%20HIV%20in%20Low-%20and%20Middle-Income%20Countries%20After%20Initial%20Concerns%20About%20Teratogenicity%20%3A%20An%20Observational%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20L.%22%2C%22lastName%22%3A%22Romo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rena%20C.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessie%20K.%22%2C%22lastName%22%3A%22Edwards%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%20S.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mercy%20W.%22%2C%22lastName%22%3A%22Maina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Penner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katarzyna%22%2C%22lastName%22%3A%22Wyka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Penh%20Sun%22%2C%22lastName%22%3A%22Ly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cordelia%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Radoslaw%22%2C%22lastName%22%3A%22Panczak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Kelvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20transition%20to%20dolutegravir-containing%20antiretroviral%20therapy%20%28ART%29%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%20was%20complicated%20by%20an%20initial%20safety%20signal%20in%20May%202018%20suggesting%20that%20exposure%20to%20dolutegravir%20at%20conception%20was%20possibly%20associated%20with%20infant%20neural%20tube%20defects.%20On%20the%20basis%20of%20additional%20evidence%2C%20in%20July%202019%2C%20the%20World%20Health%20Organization%20recommended%20dolutegravir%20for%20all%20adults%20and%20adolescents%20living%20with%20HIV.%5CnOBJECTIVE%3A%20To%20describe%20dolutegravir%20uptake%20and%20disparities%20by%20sex%20and%20age%20group%20in%20LMICs.%5CnDESIGN%3A%20Observational%20cohort%20study.%5CnSETTING%3A%2087%20sites%20that%20began%20using%20dolutegravir%20in%2011%20LMICs%20in%20the%20Asia-Pacific%3B%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%3B%20and%20sub-Saharan%20African%20regions%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnPATIENTS%3A%20134%5Cu00a0672%20patients%20aged%2016%20years%20or%20older%20who%20received%20HIV%20care%20from%20January%202017%20through%20March%202020.%5CnMEASUREMENTS%3A%20Sex%2C%20age%20group%2C%20and%20dolutegravir%20uptake%20%28that%20is%2C%20newly%20initiating%20ART%20with%20dolutegravir%20or%20switching%20to%20dolutegravir%20from%20another%20regimen%29.%5CnRESULTS%3A%20Differences%20in%20dolutegravir%20uptake%20among%20females%20of%20reproductive%20age%20%2816%20to%2049%20years%29%20emerged%20after%20the%20safety%20signal.%20By%20the%20end%20of%20follow-up%2C%20the%20cumulative%20incidence%20of%20dolutegravir%20uptake%20among%20females%2016%20to%2049%20years%20old%20was%2029.4%25%20%2895%25%20CI%2C%2029.0%25%20to%2029.7%25%29%20compared%20with%2057.7%25%20%28CI%2C%2057.2%25%20to%2058.3%25%29%20among%20males%2016%20to%2049%20years%20old.%20This%20disparity%20was%20greater%20in%20countries%20that%20began%20implementing%20dolutegravir%20before%20the%20safety%20signal%20and%20initially%20had%20highly%20restrictive%20policies%20versus%20countries%20with%20a%20later%20rollout.%20Dolutegravir%20uptake%20was%20similar%20among%20females%20and%20males%20aged%2050%20years%20or%20older.%5CnLIMITATION%3A%20Follow-up%20was%20limited%20to%206%20to%208%20months%20after%20international%20guidelines%20recommended%20expanding%20access%20to%20dolutegravir.%5CnCONCLUSION%3A%20Substantial%20disparities%20in%20dolutegravir%20uptake%20affecting%20females%20of%20reproductive%20age%20through%20early%202020%20are%20documented.%20Although%20this%20disparity%20was%20anticipated%20because%20of%20country-level%20restrictions%20on%20access%2C%20the%20results%20highlight%20its%20extent%20and%20initial%20persistence.%5CnPRIMARY%20FUNDING%20SOURCE%3A%20National%20Institutes%20of%20Health.%22%2C%22date%22%3A%222022-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7326%5C%2FM21-3037%22%2C%22ISSN%22%3A%221539-3704%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22788L2TRF%22%2C%22GXCKG69T%22%2C%22723DEGN3%22%2C%22KP8858VX%22%2C%22QDTF783W%22%2C%229CN8YLIR%22%5D%2C%22dateModified%22%3A%222022-08-22T14%3A38%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22XI4IP23F%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A11361152%2C%22username%22%3A%22allison_scarlotta%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fallison_scarlotta%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Z%5Cu00fcrcher%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EZ%26%23xFC%3Brcher%2C%20Kathrin%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECox%2C%20Samyra%20R.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBallif%2C%20Marie%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEnane%2C%20Leslie%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMarcy%2C%20Olivier%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Integrating%20services%20for%20HIV%20and%20multidrug-resistant%20tuberculosis%3A%20A%20global%20cross-sectional%20survey%20among%20ART%20clinics%20in%20low-%20and%20middle-income%20countries.%20%3Ci%3EPLOS%20Global%20Public%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E2%3C%5C%2Fi%3E%20%283%29%2C%20S.%20e0000180.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0000180%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0000180%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Integrating%20services%20for%20HIV%20and%20multidrug-resistant%20tuberculosis%3A%20A%20global%20cross-sectional%20survey%20among%20ART%20clinics%20in%20low-%20and%20middle-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathrin%22%2C%22lastName%22%3A%22Z%5Cu00fcrcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samyra%20R.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Reubenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Worarat%22%2C%22lastName%22%3A%22Imsanguan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Larissa%22%2C%22lastName%22%3A%22Otero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nishi%22%2C%22lastName%22%3A%22Suryavanshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Tornheim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20is%20the%20leading%20cause%20of%20death%20among%20PLHIV%20and%20multidrug-resistant-TB%20%28MDR-TB%29%20is%20associated%20with%20high%20mortality.%20We%20examined%20the%20management%20for%20adult%20PLHIV%20coinfected%20with%20MDR-TB%20at%20ART%20clinics%20in%20lower%20income%20countries.%20Between%202019%20and%202020%2C%20we%20conducted%20a%20cross-sectional%20survey%20at%2029%20ART%20clinics%20in%20high%20TB%20burden%20countries%20within%20the%20global%20IeDEA%20network.%20We%20used%20structured%20questionnaires%20to%20collect%20clinic-level%20data%20on%20the%20TB%20and%20HIV%20services%20and%20the%20availability%20of%20diagnostic%20tools%20and%20treatment%20for%20MDR-TB.%20Of%2029%20ART%20clinics%2C%2025%20%2886%25%29%20were%20in%20urban%20areas%20and%2019%20%2866%25%29%20were%20tertiary%20care%20clinics.%20Integrated%20HIV-TB%20services%20were%20reported%20at%2025%20%2886%25%29%20ART%20clinics%20for%20pan-susceptible%20TB%2C%20and%2014%20%2848%25%29%20clinics%20reported%20full%20MDR-TB%20services%20on-site%2C%20i.e.%20drug%20susceptibility%20testing%20%5BDST%5D%20and%20MDR-TB%20treatment.%20Some%20form%20of%20DST%20was%20available%20on-site%20at%2022%20%2876%25%29%20clinics%2C%20while%20the%20remainder%20referred%20testing%20off-site.%20On-site%20DST%20for%20second-line%20drugs%20was%20available%20at%209%20%2831%25%29%20clinics.%20MDR-TB%20treatment%20was%20delivered%20on-site%20at%2015%20%2852%25%29%20clinics%2C%20with%2010%20individualizing%20treatment%20based%20on%20DST%20results%20and%20five%20using%20standardized%20regimens%20alone.%20Bedaquiline%20was%20routinely%20available%20at%205%20%2817%25%29%20clinics%20and%20delamanid%20at%203%20%2810%25%29%20clinics.%20Although%20most%20ART%20clinics%20reported%20having%20integrated%20HIV%20and%20TB%20services%2C%20few%20had%20fully%20integrated%20MDR-TB%20services.%20There%20is%20a%20continued%20need%20for%20increased%20access%20to%20diagnostic%20and%20treatment%20options%20for%20MDR-TB%20patients%20and%20better%20integration%20of%20MDR-TB%20services%20into%20the%20HIV%20care%20continuum.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pgph.0000180%22%2C%22ISSN%22%3A%222767-3375%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22FK7XQRJZ%22%2C%22788L2TRF%22%2C%22GXCKG69T%22%2C%22723DEGN3%22%2C%22NYK75KNC%22%2C%22KP8858VX%22%2C%22QDTF783W%22%2C%229CN8YLIR%22%5D%2C%22dateModified%22%3A%222023-08-12T13%3A15%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22MN5D5744%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriaga%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EArriaga%2C%20Mar%26%23xED%3Ba%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKarim%2C%20Farina%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EQueiroz%2C%20Artur%20T.%20L.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBarreto-Duarte%2C%20Beatriz%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Effect%20of%20Dysglycemia%20on%20Urinary%20Lipid%20Mediator%20Profiles%20in%20Persons%20With%20Pulmonary%20Tuberculosis.%20%3Ci%3EFrontiers%20in%20Immunology%3C%5C%2Fi%3E%2C%20%3Ci%3E13%3C%5C%2Fi%3E%2C%20S.%20919802.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2022.919802%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2022.919802%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20Dysglycemia%20on%20Urinary%20Lipid%20Mediator%20Profiles%20in%20Persons%20With%20Pulmonary%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farina%22%2C%22lastName%22%3A%22Karim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caio%22%2C%22lastName%22%3A%22Sales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahomed-Yunus%20S.%22%2C%22lastName%22%3A%22Moosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matilda%22%2C%22lastName%22%3A%22Mazibuko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ginger%20L.%22%2C%22lastName%22%3A%22Milne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%20Henrique%22%2C%22lastName%22%3A%22Serezani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20R.%22%2C%22lastName%22%3A%22Koethe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alasdair%22%2C%22lastName%22%3A%22Leslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Oxidized%20lipid%20mediators%20such%20as%20eicosanoids%20play%20a%20central%20role%20in%20the%20inflammatory%20response%20associated%20with%20tuberculosis%20%28TB%29%20pathogenesis.%20Diabetes%20mellitus%20%28DM%29%20leads%20to%20marked%20changes%20in%20lipid%20mediators%20in%20persons%20with%20TB.%20However%2C%20the%20associations%20between%20diabetes-related%20changes%20in%20lipid%20mediators%20and%20clearance%20of%20M.%20tuberculosis%20%28Mtb%29%20among%20persons%20on%20anti-TB%20treatment%20%28ATT%29%20are%20unknown.%20Quantification%20of%20urinary%20eicosanoid%20metabolites%20can%20provide%20insights%20into%20the%20circulating%20lipid%20mediators%20involved%20in%20Mtb%20immune%20responses.%5CnMethods%3A%20We%20conducted%20a%20multi-site%20prospective%20observational%20study%20among%20adults%20with%20drug-sensitive%20pulmonary%20TB%20and%20controls%20without%20active%20TB%3B%20both%20groups%20had%20sub-groups%20with%20or%20without%20dysglycemia%20at%20baseline.%20Participants%20were%20enrolled%20from%20RePORT-Brazil%20%28Salvador%20site%29%20and%20RePORT-South%20Africa%20%28Durban%20site%29%20and%20stratified%20according%20to%20TB%20status%20and%20baseline%20glycated%20hemoglobin%20levels%3A%20a%29%20TB-dysglycemia%20%28n%3D69%29%3B%20b%29%20TB-normoglycemia%20%28n%3D64%29%3B%20c%29%20non-TB%5C%2Fdysglycemia%20%28n%3D31%29%3B%20d%29%20non-TB%5C%2Fnon-dysglycemia%20%28n%3D29%29.%20We%20evaluated%20the%20following%20urinary%20eicosanoid%20metabolites%3A%2011%5Cu03b1-hydroxy-9%2C15-dioxo-2%2C3%2C4%2C5-tetranor-prostane-1%2C20-dioic%20acid%20%28major%20urinary%20metabolite%20of%20prostaglandin%20E2%2C%20PGE-M%29%2C%20tetranor-PGE1%20%28metabolite%20of%20PGE2%2C%20TN-E%29%2C%209%5Cu03b1-hydroxy-11%2C15-dioxo-2%2C3%2C4%2C5-tetranor-prostane-1%2C20-dioic%20acid%20%28metabolite%20of%20PGD2%2C%20PGD-M%29%2C%2011-dehydro-thromboxane%20B2%20%2811dTxB2%29%2C%202%2C3-dinor-6-keto-PGF1%5Cu03b1%20%28prostaglandin%20I%20metabolite%2C%20PGI-M%29%2C%20and%20leukotriene%20E4%20%28LTE4%29.%20Comparisons%20between%20the%20study%20groups%20were%20performed%20at%20three%20time%20points%3A%20before%20ATT%20and%202%20and%206%20months%20after%20initiating%20therapy.%5CnResults%3A%20PGE-M%20and%20LTE4%20values%20were%20consistently%20higher%20at%20all%20three%20time-points%20in%20the%20TB-dysglycemia%20group%20compared%20to%20the%20other%20groups%20%28p%3C0.001%29.%20In%20addition%2C%20there%20was%20a%20significant%20decrease%20in%20PGI-M%20and%20LTE4%20levels%20from%20baseline%20to%20month%206%20in%20the%20TB-dysglycemia%20and%20TB-normoglycemia%20groups.%20Finally%2C%20TB-dysglycemia%20was%20independently%20associated%20with%20increased%20concentrations%20of%20PGD-M%2C%20PGI-M%2C%20and%20LTE4%20at%20baseline%20in%20a%20multivariable%20model%20adjusting%20for%20age%2C%20sex%2C%20BMI%2C%20and%20study%20site.%20These%20associations%20were%20not%20affected%20by%20HIV%20status.%5CnConclusion%3A%20The%20urinary%20eicosanoid%20metabolite%20profile%20was%20associated%20with%20TB-dysglycemia%20before%20and%20during%20ATT.%20These%20observations%20can%20help%20identify%20the%20mechanisms%20involved%20in%20the%20pathogenesis%20of%20TB-dysglycemia%2C%20and%20potential%20biomarkers%20of%20TB%20treatment%20outcomes%2C%20including%20among%20persons%20with%20dysglycemia.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2022.919802%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22GXCKG69T%22%5D%2C%22dateModified%22%3A%222022-08-22T14%3A17%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22HLET9LYX%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ara%5Cu00fajo-Pereira%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBarreto-Duarte%2C%20Beatriz%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EArriaga%2C%20Mar%26%23xED%3Ba%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusselwhite%2C%20Laura%20W.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EVinhaes%2C%20Caian%20L.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Relationship%20Between%20Anemia%20and%20Systemic%20Inflammation%20in%20People%20Living%20With%20HIV%20and%20Tuberculosis%3A%20A%20Sub-Analysis%20of%20the%20CADIRIS%20Clinical%20Trial.%20%3Ci%3EFrontiers%20in%20Immunology%3C%5C%2Fi%3E%2C%20%3Ci%3E13%3C%5C%2Fi%3E%2C%20S.%20916216.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2022.916216%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2022.916216%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Relationship%20Between%20Anemia%20and%20Systemic%20Inflammation%20in%20People%20Living%20With%20HIV%20and%20Tuberculosis%3A%20A%20Sub-Analysis%20of%20the%20CADIRIS%20Clinical%20Trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20W.%22%2C%22lastName%22%3A%22Musselwhite%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzaran-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Rupert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luis%20J.%22%2C%22lastName%22%3A%22Montaner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20M.%22%2C%22lastName%22%3A%22Lederman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irini%22%2C%22lastName%22%3A%22Sereti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%20Sierra%22%2C%22lastName%22%3A%22Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22People%20with%20HIV%20%28PWH%29%20are%20at%20increased%20risk%20of%20developing%20active%20tuberculosis%20%28TB%29%2C%20and%20anemia%20is%20a%20common%20complication%20in%20both%20conditions.%20Anemia%20in%20TB%20patients%20has%20been%20linked%20to%20immune%20activation%2C%20levels%20of%20inflammatory%20biomarkers%20in%20blood%2C%20and%20risk%20for%20HIV%20disease%20progression%20and%20death.%20In%20this%20study%20we%20show%20that%20anemia%20was%20associated%20with%20a%20more%20pronounced%20inflammatory%20profile%20in%20HIV-TB%20coinfected%20persons%20in%20a%20cohort%20of%20159%20individuals%20with%20advanced%20HIV%20disease%20%28CD4%20count%20%3C%20100%20cells%5C%2F%5Cu00b5L%29%20recruited%20as%20part%20of%20a%20randomized%20clinical%20trial%20%28NCT00988780%29.%20A%20panel%20of%20plasma%20biomarkers%20was%20assessed%20on%20plasma%20obtained%20prior%20to%20combination%20antiretroviral%20therapy%20%28cART%29%20initiation.%20We%20performed%20a%20series%20of%20multidimensional%20analyses%20including%20clinical%20variables%20and%20concentrations%20of%20inflammatory%20biomarkers%20to%20profile%20systemic%20inflammation%20of%20PWH%20with%20and%20without%20anemia.%20We%20observed%20that%20TB%20participants%20presented%20with%20moderately%20lower%20levels%20of%20hemoglobin%20than%20non-TB%20participants.%20These%20participants%20also%20presented%20a%20higher%20Degree%20of%20Inflammatory%20Perturbation%20%28DIP%29%20score%2C%20related%20to%20increased%20levels%20of%20IFN-%5Cu03b3%20and%20TNF.%20The%20DIP%20was%20associated%20with%20TB%20coinfection%20and%20anemia%20before%20cART%20initiation.%20Future%20mechanistic%20studies%20are%20warranted%20to%20assess%20the%20determinants%20of%20such%20associations%20and%20the%20implications%20on%20treatment%20outcomes.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2022.916216%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22A8CVXGYW%22%2C%22GXCKG69T%22%5D%2C%22dateModified%22%3A%222022-08-03T08%3A12%3A35Z%22%7D%7D%5D%7D
Brazier, Ellen; Ajeh, Rogers; Maruri, Fernanda; Musick, Beverly; Freeman, Aimee et al. (2022). Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium.
Journal of the International AIDS Society,
25 (12), S. e26036.
http://doi.org/10.1002/jia2.26036.
Sobral, Luciana; Arriaga, María B.; Souza, Alexandra B.; Araújo-Pereira, Mariana; Barreto-Duarte, Beatriz et al. (2022). Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study.
Lancet Regional Health. Americas,
15, S. 100358.
http://doi.org/10.1016/j.lana.2022.100358.
Lewis, Judith T.; Stephens, Jeremy; Musick, Beverly; Brown, Steven; Malateste, Karen et al. (2022). The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium.
Journal of Biomedical Informatics,
131, S. 104110.
http://doi.org/10.1016/j.jbi.2022.104110.
Crabtree-Ramirez, Brenda; Jenkins, Cathy A.; Shepherd, Bryan E.; Jayathilake, Karu; Veloso, Valdilea G. et al. (2022). Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy.
BMC Infectious Diseases,
22 (1), S. 341.
http://doi.org/10.1186/s12879-022-07330-5.
Justice, Amy C.; Goetz, Matthew B.; Stewart, Cameron N.; Hogan, Brenna C.; Humes, Elizabeth et al. (2022). Delayed presentation of HIV among older individuals: a growing problem.
The Lancet. HIV,
9 (4), S. e269–e280.
http://doi.org/10.1016/S2352-3018(22)00003-0.
Antimycobacterial Susceptibility Testing Group (2022). Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.
The European Respiratory Journal,
59 (4), S. 2200166.
http://doi.org/10.1183/13993003.00166-2022.
Coelho, Lara E.; Jenkins, Cathy A.; Shepherd, Bryan E.; Pape, Jean W.; Mejia Cordero, Fernando et al. (2022). Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America.
Lancet Regional Health. Americas,
8, S. 100173.
http://doi.org/10.1016/j.lana.2021.100173.
Caro-Vega, Yanink; Rebeiro, Peter F.; Shepherd, Bryan E.; Belaunzarán-Zamudio, Pablo F.; Crabtree-Ramirez, Brenda et al. (2022). Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study.
Lancet Regional Health. Americas,
8, S. 100175.
http://doi.org/10.1016/j.lana.2021.100175.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration; Jesson, Julie; Crichton, Siobhan; Quartagno, Matteo; Yotebieng, Marcel et al. (2022). Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis.
Journal of the International AIDS Society,
25 (3), S. e25871.
http://doi.org/10.1002/jia2.25871.
Romo, Matthew L.; Patel, Rena C.; Edwards, Jessie K.; Humphrey, John M.; Musick, Beverly S. et al. (2022). Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study.
Annals of Internal Medicine,
175 (1), S. 84–94.
http://doi.org/10.7326/M21-3037.
Zürcher, Kathrin; Cox, Samyra R.; Ballif, Marie; Enane, Leslie A.; Marcy, Olivier et al. (2022). Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries.
PLOS Global Public Health,
2 (3), S. e0000180.
http://doi.org/10.1371/journal.pgph.0000180.
Arriaga, María B.; Karim, Farina; Queiroz, Artur T. L.; Araújo-Pereira, Mariana; Barreto-Duarte, Beatriz et al. (2022). Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis.
Frontiers in Immunology,
13, S. 919802.
http://doi.org/10.3389/fimmu.2022.919802.
Araújo-Pereira, Mariana; Barreto-Duarte, Beatriz; Arriaga, María B.; Musselwhite, Laura W.; Vinhaes, Caian L. et al. (2022). Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical Trial.
Frontiers in Immunology,
13, S. 916216.
http://doi.org/10.3389/fimmu.2022.916216.
2021
Castilho, Jessica L.; Kim, Ahra; Jenkins, Cathy A.; Grinsztejn, Beatriz; Gotuzzo, Eduardo et al. (2021). Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America. Journal of the International AIDS Society, 24 (1). http://doi.org/10.1002/jia2.25658.
Pereira, Gerson Fernando Mendes; Kim, Ahra; Jalil, Emilia M.; Fernandes Fonseca, Fernanda; Shepherd, Bryan E. et al. (2021). Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study. The Lancet. HIV, 8 (1), S. e33–e41. http://doi.org/10.1016/S2352-3018(20)30268-X.
Tsondai, Priscilla Ruvimbo; Davies, Mary-Ann; Singtoroj, Thida; Maxwell, Nicola; McGowan, Catherine C. et al. (2021). Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. The Pediatric Infectious Disease Journal. http://doi.org/10.1097/INF.0000000000003059.
Rodrigues, Amanda; Struchiner, Claudio J.; Coelho, Lara E.; Veloso, Valdilea G.; Grinsztejn, Beatriz et al. (2021). Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment. BMC Public Health, 21 (1), S. 389. http://doi.org/10.1186/s12889-021-10421-8.
Peetluk, Lauren S.; Ridolfi, Felipe M.; Rebeiro, Peter F.; Liu, Dandan; Rolla, Valeria C. et al. (2021). Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults. BMJ Open, 11 (3), S. e044687. http://doi.org/10.1136/bmjopen-2020-044687.
Brazier, Ellen; Tymejczyk, Olga; Zaniewski, Elizabeth; Egger, Matthias; Wools-Kaloustian, Kara et al. (2021). Effects of national adoption of Treat-All guidelines on pre-ART CD4 testing and viral load monitoring after ART initiation: A regression discontinuity analysis. Clinical Infectious Diseases, S. ciab222. http://doi.org/10.1093/cid/ciab222.
Eden, Svetlana K.; Li, Chun & Shepherd, Bryan E. (2021). Nonparametric estimation of Spearman’s rank correlation with bivariate survival data. Biometrics. http://doi.org/10.1111/biom.13453.
Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2021). Improved generalized raking estimators to address dependent covariate and failure-time outcome error. Biometrical Journal. Biometrische Zeitschrift. http://doi.org/10.1002/bimj.202000187.
McMahon, Devon E.; Semeere, Aggrey; Laker-Oketta, Miriam; Byakwaga, Helen; Mugglin, Catrina et al. (2021). Global disparities in skin cancer services at HIV treatment centers across 29 countries. The Journal of Investigative Dermatology. http://doi.org/10.1016/j.jid.2021.02.758.
Smiley, Casey L.; Rebeiro, Peter F.; Cesar, Carina; Belaunzaran-Zamudio, Pablo F.; Crabtree-Ramirez, Brenda et al. (2021). Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study. The Lancet. HIV, 8 (5), S. e266–e273. http://doi.org/10.1016/S2352-3018(20)30358-1.
Yohannes, Nathaniel T.; Jenkins, Cathy A.; Clouse, Kate; Cortés, Claudia P.; Mejía Cordero, Fernando et al. (2021). Timing of HIV diagnosis relative to pregnancy and postpartum HIV care continuum outcomes among Latin American women, 2000 to 2017. Journal of the International AIDS Society, 24 (5), S. e25740. http://doi.org/10.1002/jia2.25740.
Somerville, Kayla; Jenkins, Cathy A.; Carlucci, James G.; Person, Anna K.; Machado, Daisy M. et al. (2021). Outcomes After Second-Line Antiretroviral Therapy in Children Living With HIV in Latin America. Journal of Acquired Immune Deficiency Syndromes (1999), 87 (3), S. 993–1001. http://doi.org/10.1097/QAI.0000000000002678.
Lotspeich, Sarah C.; Shepherd, Bryan E.; Amorim, Gustavo G. C.; Shaw, Pamela A. & Tao, Ran (2021). Efficient odds ratio estimation under two-phase sampling using error-prone data from a multi-national HIV research cohort. Biometrics. http://doi.org/10.1111/biom.13512.
Peetluk, Lauren S.; Rebeiro, Peter F.; Ridolfi, Felipe M.; Andrade, Bruno B.; Cordeiro-Santos, Marcelo et al. (2021). A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, S. ciab598. http://doi.org/10.1093/cid/ciab598.
Hovhannisyan, Lyolya; Coelho, Lara E.; Velasque, Luciane; De Boni, Raquel B.; Clark, Jesse et al. (2021). Multilevel Analysis of Individual and Neighborhood Characteristics Associated with Viral Suppression Among Adults with HIV in Rio de Janeiro, Brazil. AIDS and Behavior. http://doi.org/10.1007/s10461-021-03450-2.
Johnson, Leigh F.; Kariminia, Azar; Trickey, Adam; Yiannoutsos, Constantin T.; Ekouevi, Didier K. et al. (2021). Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. Journal of the International AIDS Society, 24 Suppl 5, S. e25776. http://doi.org/10.1002/jia2.25776.
Souza, Alexandra Brito; Arriaga, María B.; Amorim, Gustavo; Araújo-Pereira, Mariana; Nogueira, Betânia M. F. et al. (2021). Determinants of losses in the latent tuberculosis infection cascade of care in Brazil. BMJ Global Health, 6 (9), S. e005969. http://doi.org/10.1136/bmjgh-2021-005969.
Arriaga, María B.; Araújo-Pereira, Mariana; Barreto-Duarte, Beatriz; Nogueira, Betânia; Freire, Maria Vitória C. N. S. et al. (2021). The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study. The Journal of Infectious Diseases, S. jiab427. http://doi.org/10.1093/infdis/jiab427.
Costa, Allyson G.; Carvalho, Brenda K. S.; Araújo-Pereira, Mariana; Ibiapina, Hiochelson N. S.; Spener-Gomes, Renata et al. (2021). Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil. Microbiology Spectrum, S. e0116321. http://doi.org/10.1128/Spectrum.01163-21.
Carvalho, Anna Cristina C.; Amorim, Gustavo; Melo, Mayla G. M.; Silveira, Ana Karla A.; Vargas, Pedro H. L. et al. (2021). Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study. Frontiers in Immunology, 12, S. 661934. http://doi.org/10.3389/fimmu.2021.661934.
Han, Win Min; Law, Matthew G.; Egger, Matthias; Wools-Kaloustian, Kara; Moore, Richard et al. (2021). Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. The Lancet HIV, 8 (12), S. e766–e775. http://doi.org/10.1016/S2352-3018(21)00265-4.
Joseph, Yvetot; Yao, Zhiwen; Dua, Akanksha; Severe, Patrice; Collins, Sean E. et al. (2021). Long‐term mortality after tuberculosis treatment among persons living with HIV in Haiti. Journal of the International AIDS Society, 24 (7). http://doi.org/10.1002/jia2.25721.
Kassanjee, Reshma; Johnson, Leigh F.; Zaniewski, Elizabeth; Ballif, Marie; Christ, Benedikt et al. (2021). Global HIV mortality trends among children on antiretroviral treatment corrected for under‐reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration. Journal of the International AIDS Society, 24 (S5). http://doi.org/10.1002/jia2.25780.
Zürcher, Kathrin; Reichmuth, Martina L.; Ballif, Marie; Loiseau, Chloé; Borrell, Sonia et al. (2021). Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. The Lancet Microbe, 2 (7), S. e320–e330. http://doi.org/10.1016/S2666-5247(21)00044-6.
2020
Humphrey, John M.; Mpofu, Philani; Pettit, April C.; Musick, Beverly; Carter, E. Jane et al. (2020). Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium. Open Forum Infectious Diseases, 7 (1), S. ofaa006–ofaa006. http://doi.org/10.1093/ofid/ofaa006.
IeDEA and COHERE in EuroCoord Cohort Collaboration (2020). All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas. AIDS, 34 (2), S. 277–289. http://doi.org/10.1097/QAD.0000000000002399.
Rohner, Eliane; Bütikofer, Lukas; Schmidlin, Kurt; Sengayi, Mazvita; Maskew, Mhairi et al. (2020). Cervical cancer risk in women living with HIV across four continents: A multicohort study. International Journal of Cancer, 146 (3), S. 601–609. http://doi.org/10.1002/ijc.32260.
Lotspeich, Sarah C.; Giganti, Mark J.; Maia, Marcelle; Vieira, Renalice; Machado, Daisy Maria et al. (2020). Self-audits as alternatives to travel-audits for improving data quality in the Caribbean, Central and South America network for HIV epidemiology. Journal of Clinical and Translational Science, 4 (2), S. 125–132. http://doi.org/10.1017/cts.2019.442.
Patel, Kunjal; Smith, Colette; Collins, Intira Jeannie; Goodall, Ruth; Abrams, Elaine J. et al. (2020). Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis. Journal of the International AIDS Society, 23 (4). http://doi.org/10.1002/jia2.25477.
Jesson, Julie; Desmonde, Sophie; Yiannoutsos, Constantin T.; Patten, Gabriela; Malateste, Karen et al. (2020). Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Research Notes, 13 (1), S. 249–249. http://doi.org/10.1186/s13104-020-05081-7.
Rebeiro, Peter F.; Cohen, Mollie J.; Ewing, Heather M.; Figueiredo, Marina Cruvinel; Peetluk, Lauren Saag et al. (2020). Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies. BMC Public Health, 20 (1), S. 897–897. http://doi.org/10.1186/s12889-020-09053-1.
Duda, Stephany N.; Musick, Beverly S.; Davies, Mary-Ann; Sohn, Annette H.; Ledergerber, Bruno et al. (2020). The IeDEA Data Exchange Standard: a common data model for global HIV cohort collaboration (preprint). Health Informatics. https://doi.org/10.1101/2020.07.22.20159921
Loiseau, Chloé; Brites, Daniela; Reinhard, Miriam; Zürcher, Kathrin; Borrell, Sonia et al. (2020). HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. http://doi.org/10.1128/AAC.00782-20.
Patten, Gabriela; Puthanakit, Thanyawee; McGowan, Catherine C.; Wools-Kaloustian, Kara; Hazra, Rohan et al. (2020). Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium. Journal of the International AIDS Society, 23 (7). http://doi.org/10.1002/jia2.25580.
Parcesepe, Angela M.; Lancaster, Kathryn; Edelman, E. Jennifer; DeBoni, Raquel; Ross, Jeremy et al. (2020). Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS ONE, 15 (8 August), S. e0237772–e0237772. http://doi.org/10.1371/journal.pone.0237772.
Demitto, Fernanda O.; Araújo-Pereira, Mariana; Schmaltz, Carolina A.; Sant’Anna, Flávia M.; Arriaga, María B. et al. (2020). Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV. Frontiers in Immunology, 11. http://doi.org/10.3389/fimmu.2020.588405.
Desmonde, Sophie; Neilan, Anne M.; Musick, Beverly; Patten, Gabriela; Chokephaibulkit, Kulkanya et al. (2020). Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Gl. Journal of the International AIDS Society, 23 (10), S. e25617–e25617. http://doi.org/10.1002/jia2.25617.
Rebeiro, Peter F.; Duda, Stephany N.; Wools-Kaloustian, Kara K.; Nash, Denis & Althoff, Keri N. (2020). Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses. Journal of the International AIDS Society, 23 (10), S. e25627–e25627. http://doi.org/10.1002/jia2.25627.
Reichmuth, Martina L.; Hömke, Rico; Zürcher, Kathrin; Sander, Peter; Avihingsanon, Anchalee et al. (2020). Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrobial Agents and Chemotherapy, 64 (11). http://doi.org/10.1128/AAC.00513-20.
Tao, Ran; Lotspeich, Sarah C.; Amorim, Gustavo; Shaw, Pamela A. & Shepherd, Bryan E. (2020). Efficient semiparametric inference for two-phase studies with outcome and covariate measurement errors. Statistics in Medicine, S. sim.8799-sim.8799. http://doi.org/10.1002/sim.8799.
Giganti, Mark J. & Shepherd, Bryan E. (2020). Multiple-Imputation Variance Estimation in Studies With Missing or Misclassified Inclusion Criteria. American Journal of Epidemiology, 189 (12), S. 1628–1632. http://doi.org/10.1093/aje/kwaa153.
Oliveira-de-Souza, Deivide; Vinhaes, Caian L.; Arriaga, María B.; Kumar, Nathella Pavan; Queiroz, Artur T. L. et al. (2020). Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis. Scientific Reports, 10 (1). http://doi.org/10.1038/s41598-020-68255-0.
Penn-Nicholson, Adam; Mbandi, Stanley Kimbung; Thompson, Ethan; Mendelsohn, Simon C.; Suliman, Sara et al. (2020). RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Scientific Reports, 10 (1). http://doi.org/10.1038/s41598-020-65043-8.
Barreto-Duarte, Beatriz; Sterling, Timothy R.; Fiske, Christina T.; Almeida, Alexandre; Nochowicz, Cynthia H. et al. (2020). Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis. Frontiers in Immunology, 11, S. 605338. http://doi.org/10.3389/fimmu.2020.605338.
Belaunzaran-Zamudio, Pablo F.; Caro-Vega, Yanink; Giganti, Mark J.; Castilho, Jessica L.; Crabtree-Ramirez, Brenda E. et al. (2020). Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America. PloS One, 15 (6), S. e0233965–e0233965. http://doi.org/10.1371/journal.pone.0233965.
Boettiger, David C.; Escuder, Maria Mercedes; Law, Matthew G.; Veloso, Valdiléa; Souza, Rosa A. et al. (2020). Cardiovascular disease among people living with HIV in Brazil. Tropical Medicine and International Health. http://doi.org/10.1111/tmi.13405.
Giganti, Mark J.; Shaw, Pamela A.; Chen, Guanhua; Bebawy, Sally S.; Turner, Megan M. et al. (2020). Accounting for dependent errors in predictors and time-to-event outcomes using electronic health records, validation samples and multiple imputation. Annals of Applied Statistics, 14 (2), S. 1045–1061. http://doi.org/10.1214/20-AOAS1343.
Musayón-Oblitas, Flor Yesenia; Cárcamo, Cesar Paul; Gimbel, Sarah; Zarate, Juan Ignacio Echevarria & Espinoza, Ana Beatriz Graña (2020). Validation of a counseling guide for adherence to antiretroviral therapy using implementation science. Revista Latino-Americana de Enfermagem, 28, S. e3228–e3228. http://doi.org/10.1590/1518-8345.3117.3228.
Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2020). Raking and regression calibration: Methods to address bias from correlated covariate and time-to-event error. Statistics in Medicine. http://doi.org/10.1002/sim.8793.
Safe, Izabella P.; Amaral, Eduardo P.; Araújo-Pereira, Mariana; Lacerda, Marcus V. G.; Printes, Vitoria S. et al. (2020). Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial. Frontiers in Immunology, 11, S. 602589. http://doi.org/10.3389/fimmu.2020.602589.
2019
Castilho, Jessica L.; Escuder, Maria M.; Veloso, Valdiléa; Gomes, Jackeline O.; Jayathilake, Karu et al. (2019). Trends and predictors of non‐communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil. Journal of the International AIDS Society, 22 (1), S. e25233–e25233. http://doi.org/10.1002/jia2.25233.
Crabtree-Ramírez, B.; Jenkins, C.; Jayathilake, K.; Carriquiry, G.; Veloso, V. et al. (2019). HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease. The International Journal of Tuberculosis and Lung Disease, 23 (3), S. 306–314. http://doi.org/10.5588/ijtld.18.0111.
Gygli, Sebastian M.; Keller, Peter M.; Ballif, Marie; Blöchliger, Nicolas; Hömke, Rico et al. (2019). Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 63 (4). http://doi.org/10.1128/AAC.02175-18.
Oliveira-de-Souza, Deivide; Vinhaes, Caian L.; Arriaga, Maria B.; Kumar, Nathella Pavan; Cubillos-Angulo, Juan M. et al. (2019). Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations. Scientific Reports, 9 (1), S. 8002–8002. http://doi.org/10.1038/s41598-019-44513-8.
Perez-Patrigeon, S.; Camiro-Zúñiga, A.; Jaramillo-Jante, M. R.; Belaunzarán-Zamudio, P. F.; Crabtree-Ramírez, B. et al. (2019). Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphones. HIV Medicine, 20 (5), S. 308–316. http://doi.org/10.1111/hiv.12713.
Brazier, Ellen; Maruri, Fernanda; Duda, Stephany N.; Tymejczyk, Olga; Wester, C. William et al. (2019). Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. Journal of the International AIDS Society, 22 (7), S. e25331–e25331. http://doi.org/10.1002/jia2.25331.
Cubillos-Angulo, Juan Manuel; Arriaga, María B.; Silva, Elisângela C.; Müller, Beatriz L. A.; Ramalho, Daniela M. P. et al. (2019). Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 69 (6), S. 1027–1035. http://doi.org/10.1093/cid/ciy1001.
Zürcher, Kathrin; Ballif, Marie; Kiertiburanakul, Sasisopin; Chenal, Henri; Yotebieng, Marcel et al. (2019). Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. Journal of the International AIDS Society, 22 (9), S. e25392–e25392. http://doi.org/10.1002/jia2.25392.
Belaunzarán-Zamudio, Pablo F.; Caro-Vega, Yanink N.; Shepherd, Bryan E.; Rebeiro, Peter F.; Crabtree-Ramírez, Brenda E. et al. (2019). The Population Impact of Late Presentation with Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America. American Journal of Epidemiology. http://doi.org/10.1093/aje/kwz252.
Koenig, Serena P.; Kim, Ahra; Shepherd, Bryan E.; Cesar, Carina; Veloso, Valdilea et al. (2019). Increased Mortality after Tuberculosis Treatment Completion in Persons with HIV in Latin America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/ciz1032.
Silveira-Mattos, Paulo S.; Barreto-Duarte, Beatriz; Vasconcelos, Beatriz; Fukutani, Kiyoshi F.; Vinhaes, Caian L. et al. (2019). Differential expression of activation markers by Mycobacterium tuberculosis-specific CD4+ T-cell distinguishes extrapulmonary from pulmonary tuberculosis and latent infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/ciz1070.
Jesson, Julie; Schomaker, Michael; Malasteste, Karen; Wati, Dewi K.; Kariminia, Azar et al. (2019). Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. Journal of the International AIDS Society, 22 (11), S. e25412–e25412. http://doi.org/10.1002/jia2.25412.
Peetluk, Lauren S.; Rebeiro, Peter F.; Cordeiro-Santos, Marcelo; Kritski, Afranio; Andrade, Bruno B. et al. (2019). Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis. The Journal of Infectious Diseases. http://doi.org/10.1093/infdis/jiz595.
Vinhaes, Caian L.; Oliveira-de-Souza, Deivide; Silveira-Mattos, Paulo S.; Nogueira, Betania; Shi, Ruiru et al. (2019). Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study. Cytokine, 123, S. 154759–154759. http://doi.org/10.1016/j.cyto.2019.154759.
Crabtree-Ramírez, Brenda E.; Caro-Vega, Yanink; Belaunzarán-Zamudio, Pablo F.; Shepherd, Bryan E.; Rebeiro, Peter F. et al. (2019). Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort study. Journal of the International AIDS Society, 22 (12), S. e25413–e25413. http://doi.org/10.1002/jia2.25413.
Giganti, Mark J.; Shepherd, Bryan E.; Caro-Vega, Yanink; Luz, Paula M.; Rebeiro, Peter F. et al. (2019). The impact of data quality and source data verification on epidemiologic inference: a practical application using HIV observational data. BMC Public Health, 19 (1), S. 1748–1748. http://doi.org/10.1186/s12889-019-8105-2.
Johnson, Leigh F.; Anderegg, Nanina; Zaniewski, Elizabeth; Eaton, Jeffrey W.; Rebeiro, Peter F. et al. (2019). Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration. AIDS (London, England), 33 Suppl 3, S. S283–S294. http://doi.org/10.1097/QAD.0000000000002358.
Pettit, April C.; Jenkins, Cathy A.; Blevins Peratikos, Meridith; Yotebieng, Marcel; Diero, Lameck et al. (2019). Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. Journal of the International AIDS Society, 22 (12), S. e25423–e25423. http://doi.org/10.1002/jia2.25423.
Stover, John; Glaubius, Robert; Mofenson, Lynne; Dugdale, Caitlin M.; Davies, Mary Ann et al. (2019). Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS, 33, S. S227–S234. http://doi.org/10.1097/QAD.0000000000002357.
Rivera, V. R.; Lu, L.; Ocheretina, O.; Jean Juste, M. A.; Julma, P. et al. (2019). Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 23 (11), S. 1217–1222. http://doi.org/10.5588/ijtld.18.0835.
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin T.; Vinikoor, Michael; van Lettow, Monique et al. (2019). Changes in rapid HIV treatment initiation after national “treat all” policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis. PLoS Medicine, 16 (6), S. e1002822–e1002822. http://doi.org/10.1371/journal.pmed.1002822.
2018
IeDEA and COHERE Cohort Collaborations (2018). Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/cix915.
Wolff, Marcelo J.; Cortes, Claudia P.; Mejìa, Fernando A.; Padgett, Denis; Belaunzarán-Zamudio, Pablo et al. (2018). Evaluating the care cascade after antiretroviral therapy initiation in Latin America. International Journal of STD & AIDS, 29 (1), S. 4–12. http://doi.org/10.1177/0956462417714094.
Caro-Vega, Yanink; Belaunzarán-Zamudio, Pablo F.; Crabtree-Ramírez, Brenda E.; Shepherd, Bryan E.; Grinsztejn, Beatriz et al. (2018). Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America. Open Forum Infectious Diseases, 5 (3), S. ofy004–ofy004. http://doi.org/10.1093/ofid/ofy004.
Carriquiry, Gabriela; Giganti, Mark J.; Castilho, Jessica L.; Jayathilake, Karu; Cahn, Pedro et al. (2018). Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort. Journal of the International AIDS Society, 21 (3), S. e25088–e25088. http://doi.org/10.1002/jia2.25088.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, CIPHER; Slogrove, Amy L.; Schomaker, Michael; Davies, Mary-Ann; Williams, Paige et al. (2018). The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Medicine, 15 (3), S. e1002514–e1002514. http://doi.org/10.1371/journal.pmed.1002514.
De Boni, Raquel B.; Peratikos, Meridith B.; Shepherd, Bryan E.; Grinsztejn, Beatriz; Cortés, Claudia et al. (2018). Is substance use associated with HIV cascade outcomes in Latin America? PloS One, 13 (3), S. e0194228–e0194228. http://doi.org/10.1371/journal.pone.0194228.
Parcesepe, Angela M.; Mugglin, Catrina; Nalugoda, Fred; Bernard, Charlotte; Yunihastuti, Evy et al. (2018). Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium. Journal of the International AIDS Society, 21 (3), S. e25101–e25101. http://doi.org/10.1002/jia2.25101.
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin; Wools-Kaloustian, Kara; Althoff, Keri et al. (2018). HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Medicine, 15 (3), S. e1002534–e1002534. http://doi.org/10.1371/journal.pmed.1002534.
Prochazka, Mateo; Otero, Larissa; Konda, Kelika A.; González-Lagos, Elsa; Echevarría, Juan et al. (2018). Patient-nominated supporters as facilitators for engagement in HIV care in a referral hospital in Peru: A retrospective cohort study. PloS One, 13 (4), S. e0195389–e0195389. http://doi.org/10.1371/journal.pone.0195389.
Caro-Vega, Y.; Belaunzarán-Zamudio, P. F.; Crabtree-Ramírez, B.; Shepherd, B. E.; Mejia, F. et al. (2018). Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge. Epidemiology and Infection, S. 1–4. http://doi.org/10.1017/S0950268818001346.
Desmonde, Sophie; Tanser, Franck; Vreeman, Rachel; Takassi, Elom; Edmonds, Andrew et al. (2018). Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. PLoS Medicine, 15 (5), S. e1002565–e1002565. http://doi.org/10.1371/journal.pmed.1002565.
Zamudio-Rodríguez, Alfonso; Belaunzarán-Zamudio, Pablo F.; Sierra-Madero, Juan G.; Cuellar-Rodríguez, Jennifer; Crabtree-Ramírez, Brenda E. et al. (2018). Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV. AIDS Research and Human Retroviruses, 34 (5), S. 449–455. http://doi.org/10.1089/aid.2017.0100.
Giles, Michelle L.; Achhra, Amit C.; Abraham, Alison G.; Haas, Andreas D.; Gill, Michael John et al. (2018). Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Journal of the International AIDS Society, 21 (6), S. e25149–e25149. http://doi.org/10.1002/jia2.25149.
Arrivé, Elise; Ayaya, Samuel; Davies, Mary-Ann; Chimbetete, Cleophas; Edmonds, Andrew et al. (2018). Models of support for disclosure of HIV status to HIV-infected children and adolescents in resource-limited settings. Journal of the International AIDS Society, 21 (7), S. e25157–e25157. http://doi.org/10.1002/jia2.25157.
Bakal, David R.; Coelho, Lara E.; Luz, Paula M.; Clark, Jesse L.; De Boni, Raquel B. et al. (2018). Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors. Journal of Antimicrobial Chemotherapy, 73 (8), S. 2177–2185. http://doi.org/10.1093/jac/dky145.
Coelho, Lara; Rebeiro, Peter F.; Castilho, Jessica L.; Caro-Veja, Yanink; Mejia, Fernando A. et al. (2018). Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIV Acquisition on HIV Survival in the Americas. AIDS Patient Care and STDs, 32 (8), S. 306–313. http://doi.org/10.1089/apc.2018.0028.
Guiteau Moise, Colette; Rivera, Vanessa R.; Hennessey, Kelly A.; Bellot, Clovy; Nicholas, Chris et al. (2018). A Successful Model of Expedited Antiretroviral Therapy for Clinically Stable Patients Living With HIV in Haiti. Journal of Acquired Immune Deficiency Syndromes (1999), 79 (1), S. 70–76. http://doi.org/10.1097/QAI.0000000000001725.
Rohner, Eliane & AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018). Non-Hodgkin lymphoma risk in adults living with HIV across five continents: a multicohort study. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000002003.
Panayidou, Klea; Davies, Mary-Ann; Anderegg, Nanina; Egger, Matthias & IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group (2018). Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. Journal of the International AIDS Society, 21 (11), S. e25200–e25200. http://doi.org/10.1002/jia2.25200.
Rebeiro, Peter F.; Howe, Chanelle J.; Rogers, William B.; Bebawy, Sally S.; Turner, Megan et al. (2018). The relationship between adverse neighborhood socioeconomic context and HIV continuum of care outcomes in a diverse HIV clinic cohort in the Southern United States. AIDS Care, 30 (11), S. 1426–1434. http://doi.org/10.1080/09540121.2018.1465526.
Zaniewski, Elizabeth; Tymejczyk, Olga; Kariminia, Azar; Desmonde, Sophie; Leroy, Valériane et al. (2018). IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development. Journal of Virus Eradication, 4 (Suppl 2), S. 9–15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/30515309
Caro-Vega, Yanink; Schultze, Anna; W. Efsen, Anne Marie; Post, Frank A.; Panteleev, Alexander et al. (2018). Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America. BMC Infectious Diseases, 18 (1), S. 191–191. http://doi.org/10.1186/s12879-018-3077-x.
Fink, Valeria I.; Jenkins, Cathy A.; Castilho, Jessica L.; Person, Anna K.; Shepherd, Bryan E. et al. (2018). Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America. Infectious Agents and Cancer, 13 (1), S. 16–16. http://doi.org/10.1186/s13027-018-0188-3.
Kariminia, Azar; Law, Matthew; Davies, Mary‐Ann; Vinikoor, Michael; Wools‐Kaloustian, Kara et al. (2018). Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration. Journal of the International AIDS Society, 21 (12), S. e25215–e25215. http://doi.org/10.1002/jia2.25215.
Ford, Nathan; Penazzato, Martina; Vitoria, Marco; Doherty, Meg; Davies, Mary Ann et al. (2018). The contribution of observational studies in supporting the WHO “treat all” recommendation for HIV/AIDS. Journal of Virus Eradication, 4 (Suppl 2), S. 5–8. http://doi.org/10.1016/S2055-6640(20)30346-0.
2017
Fritz, Cristin Q.; Blevins, Meridith; Lindegren, Mary Lou; Wools-Kaloutsian, Kara; Musick, Beverly S. et al. (2017). Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. Journal of the International AIDS Society, 20 (1), S. 1–14. http://doi.org/10.7448/IAS.20.1.20933.
Machado, Iona K.; Luz, Paula M.; Lake, Jordan E.; Castro, Rodolfo; Velasque, Luciane et al. (2017). Self-rated health and substance use among individuals in HIV care in Rio de Janeiro, Brazil: a cross-sectional study. International Journal of STD & AIDS, S. 956462417692278–956462417692278. http://doi.org/10.1177/0956462417692278.
Clouse, Kate; Blevins, Meridith; Lindegren, Mary Lou; Yotebieng, Marcel; Nguyen, Dung Thi et al. (2017). Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program. PloS One, 12 (2), S. e0171384–e0171384. http://doi.org/10.1371/journal.pone.0171384.
Teixeira da Silva, Daniel S.; Luz, Paula M.; Lake, Jordan E.; Cardoso, Sandra W.; Ribeiro, Sayonara et al. (2017). Poor retention in early care increases risk of mortality in a Brazilian HIV-infected clinical cohort. AIDS Care, 29 (2), S. 263–267. http://doi.org/10.1080/09540121.2016.1211610.
Coelho, Lara E.; Ribeiro, Sayonara R.; Japiassu, Andre M.; Moreira, Ronaldo I.; Lara, Priscila C. et al. (2017). 30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001352.
Coelho, Lara E.; Ribeiro, Sayonara R.; Veloso, Valdilea G.; Grinsztejn, Beatriz & Luz, Paula M. (2017). Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases, 21 (2), S. 190–195. http://doi.org/10.1016/j.bjid.2016.10.007.
Luque, Marco T.; Jenkins, Cathy A.; Shepherd, Bryan E.; Padgett, Denis; Rouzier, Vanessa et al. (2017). Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America. The Journal of Pediatrics, 182, S. 245- 252.e1. http://doi.org/10.1016/j.jpeds.2016.12.034.
Shepherd, Bryan E.; Rebeiro, Peter F. & Caribbean, Central and South America network for HIV epidemiology (2017). Brief Report: Assessing and Interpreting the Association Between Continuous Covariates and Outcomes in Observational Studies of HIV Using Splines. Journal of Acquired Immune Deficiency Syndromes (1999), 74 (3), S. e60–e63. http://doi.org/10.1097/QAI.0000000000001221.
Anderegg, Nanina; Johnson, Leigh F.; Zaniewski, Elizabeth; Althoff, Keri N.; Balestre, Eric et al. (2017). All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS (London, England), 31 Suppl 1, S. S31–S40. http://doi.org/10.1097/QAD.0000000000001321.
Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2017). Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEX. Statistics in Medicine, 37 (8), S. 1276–1289. http://doi.org/10.1002/sim.7554.
Wolff, Marcelo J.; Giganti, Mark J.; Cortes, Claudia P.; Cahn, Pedro; Grinsztejn, Beatriz et al. (2017). A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy. PloS One, 12 (6), S. e0179769–e0179769. http://doi.org/10.1371/journal.pone.0179769.
Jiamsakul, Awachana; Kariminia, Azar; Althoff, Keri N.; Cesar, Carina; Cortes, Claudia P. et al. (2017). HIV viral load suppression in adults and children receiving antiretroviral therapy – results from the IeDEA collaboration. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001499.
Rebeiro, Peter Francis; Ivey, Kelsey Sunderland; Craig, Kaylin Smith; Hulgan, Todd; Huaman, Moises Arturo et al. (2017). New Faces of HIV Infection: Age, Race, and Timing of Entry into HIV Care in the Southeastern United States. Journal of the International Association of Providers of AIDS Care, 16 (4), S. 347–352. http://doi.org/10.1177/2325957417710719.
Shepherd, Bryan E.; Blevins Peratikos, Meridith; Rebeiro, Peter F.; Duda, Stephany N. & McGowan, Catherine C. (2017). A Pragmatic Approach for Reproducible Research With Sensitive Data. American Journal of Epidemiology, 186 (4), S. 387–392. http://doi.org/10.1093/aje/kwx066.
Brown, Steven A.; Abbas, Salma; Davies, Mary-Ann; Bunupuradah, Torsak; Sohn, Annette H. et al. (2017). Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76 (1), S. 60–64. http://doi.org/10.1097/QAI.0000000000001453.
Machado, Iona K.; Luz, Paula M.; Lake, Jordan E.; Castro, Rodolfo; Velasque, Luciane et al. (2017). Substance use among HIV-infected patients in Rio de Janeiro, Brazil: Agreement between medical records and the ASSIST questionnaire. Drug and Alcohol Dependence, 178, S. 115–118. http://doi.org/10.1016/j.drugalcdep.2017.04.033.
AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord & AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord (2017). Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 65 (8), S. 1316–1326. http://doi.org/10.1093/cid/cix480.
Crabtree Ramírez, B.; Caro Vega, Y.; Shepherd, B. E.; Le, C.; Turner, M. et al. (2017). Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 63, S. 57–63. http://doi.org/10.1016/j.ijid.2017.08.004.
Rebeiro, Peter F.; Bakoyannis, Giorgos; Musick, Beverly S.; Braithwaite, Ronald S.; Wools-Kaloustian, Kara K. et al. (2017). Observational Study of the Effect of Patient Outreach on Return to Care: The Earlier the Better. Journal of Acquired Immune Deficiency Syndromes (1999), 76 (2), S. 141–148. http://doi.org/10.1097/QAI.0000000000001474.
Liu, Qi; Shepherd, Bryan E.; Li, Chun & Harrell, Frank E. (2017). Modeling continuous response variables using ordinal regression. Statistics in Medicine, 36 (27), S. 4316–4335. http://doi.org/10.1002/sim.7433.
Lamas, Cristiane C.; Coelho, Lara E.; Grinsztejn, Beatriz J. & Veloso, Valdilea G. (2017). Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study. Infection, 45 (6), S. 801–809. http://doi.org/10.1007/s15010-017-1041-0.
2016
Wolff, Marcelo; Shepherd, Bryan E.; Cortés, Claudia; Rebeiro, Peter; Cesar, Carina et al. (2016). Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network. Journal of Acquired Immune Deficiency Syndromes (1999), 71 (1), S. 102–110. http://doi.org/10.1097/QAI.0000000000000817.
Blevins, Meridith; Wehbe, Firas H.; Rebeiro, Peter F.; Caro-Vega, Yanink; McGowan, Catherine C. et al. (2016). Interactive Data Visualization for HIV Cohorts: Leveraging Data Exchange Standards to Share and Reuse Research Tools. PloS One, 11 (3), S. e0151201–e0151201. http://doi.org/10.1371/journal.pone.0151201.
Cesar, Carina; Koethe, John R.; Giganti, Mark J.; Rebeiro, Peter; Althoff, Keri N. et al. (2016). Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. Journal of the International AIDS Society, 19 (1). http://doi.org/10.7448/IAS.19.1.20684.
Coelho, Lara E.; Cardoso, Sandra W.; Amancio, Rodrigo T.; Moreira, Ronaldo I.; Ribeiro, Sayonara R. et al. (2016). Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil. BMC Infectious Diseases, 16 (1), S. 134–134. http://doi.org/10.1186/s12879-016-1462-x.
Charles, M. Katherine; Lindegren, Mary Lou; Wester, C. William; Blevins, Meridith; Sterling, Timothy R. et al. (2016). Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control (“Three I’s”) and HIV-Tuberculosis Service Integration in Lower Income Countries. PloS One, 11 (4), S. e0153243–e0153243. http://doi.org/10.1371/journal.pone.0153243.
Rebeiro, Peter F.; Cesar, Carina; Shepherd, Bryan E.; De Boni, Raquel B.; Cort?s, Claudia P. et al. (2016). Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression. Journal of the International AIDS Society, 19 (1), S. 20636–20636. http://doi.org/10.7448/IAS.19.1.20636.
Crabtree-Ramírez, Brenda; Caro-Vega, Yanink; Shepherd, Bryan E.; Grinsztejn, Beatriz; Wolff, Marcelo et al. (2016). Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America. PloS One, 11 (6), S. e0153921–e0153921. http://doi.org/10.1371/journal.pone.0153921.
Diaz, Chanelle M.; Segura, Eddy R.; Luz, Paula M.; Clark, Jesse L.; Ribeiro, Sayonara R. et al. (2016). Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study. BMC Infectious Diseases, 16 (1), S. 376–376. http://doi.org/10.1186/s12879-016-1735-4.
Coelho, Lara; Grinsztejn, Beatriz; Castilho, Jessica L.; De Boni, Raquel; Quintana, Marcel S. B. et al. (2016). Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study. The Lancet. HIV, 3 (10), S. e490-8. http://doi.org/10.1016/S2352-3018(16)30052-2.
Rachlis, Beth; Karwa, Rakhi; Chema, Celia; Pastakia, Sonak; Olsson, Sten et al. (2016). Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Safety, 39 (10), S. 959–976. http://doi.org/10.1007/s40264-016-0434-9.
De Boni, Raquel B.; Shepherd, Bryan E.; Grinsztejn, Beatriz; Cesar, Carina; Cortés, Claudia et al. (2016). Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America. AIDS and Behavior, 20 (11), S. 2692–2699. http://doi.org/10.1007/s10461-016-1398-6.
Cesar, Carina; Blugerman, Gabriela; Valiente, José Antonio; Rebeiro, Peter; Sued, Omar et al. (2016). The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital. Revista Panamericana de Salud Publica = Pan American Journal of Public Health, 40 (6), S. 448–454. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28718494
Shepherd, Bryan E.; Li, Chun & Liu, Qi (2016). Probability-scale residuals for continuous, discrete, and censored data. The Canadian Journal of Statistics = Revue Canadienne de Statistique, 44 (4), S. 463–479. http://doi.org/10.1002/cjs.11302.
Althoff, Keri N.; Rebeiro, Peter F.; Hanna, David B.; Padgett, Denis; Horberg, Michael A. et al. (2016). A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. Journal of the International AIDS Society, 19 (1), S. 20707–20707. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27049052
2015
Ballif, Marie; Renner, Lorna; Dusingize, Jean Claude; Leroy, Valeriane; Ayaya, Samuel et al. (2015). Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. Journal of the Pediatric Infectious Diseases Society, 4 (1), S. 30–38. http://doi.org/10.1093/jpids/piu020.
Luz, Paula M.; Belaunzarán-Zamudio, Pablo F.; Crabtree-Ramírez, Brenda; Caro-Vega, Yanink; Hoces, Daniel et al. (2015). CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean. Open Forum Infectious Diseases, 2 (2), S. ofv079–ofv079. http://doi.org/10.1093/ofid/ofv079.
Giganti, Mark J.; Luz, Paula M.; Caro-Vega, Yanink; Cesar, Carina; Padgett, Denis et al. (2015). A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean. AIDS Research and Human Retroviruses, 31 (5), S. 496–503. http://doi.org/10.1089/aid.2014.0241.
Castilho, Jessica L.; Levi, José Eduardo; Luz, Paula M.; Cambou, Mary Catherine; Vanni, Tazio et al. (2015). A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil. BMC Cancer, 15 (1), S. 478–478. http://doi.org/10.1186/s12885-015-1486-4.
Belaunzarán-Zamudio, Pablo F.; Caro-Vega, Yanink N.; Shepherd, Bryan E.; Crabtree-Ramírez, Brenda E.; Luz, Paula M. et al. (2015). Monitoring of HIV treatment in seven countries in the WHO Region of the Americas. Bulletin of the World Health Organization, 93 (8), S. 529–539. http://doi.org/10.2471/BLT.14.147447.
Caro-Vega, Yanink; del Rio, Carlos; Dias Lima, Viviane; Lopez-Cervantes, Malaquias; Crabtree-Ramirez, Brenda et al. (2015). Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model. PLOS ONE, 10 (8), S. e0136534–e0136534. http://doi.org/10.1371/journal.pone.0136534.
Crabtree-Ramírez, Brenda; Vega, Yanink Neried Caro; Shepherd, Bryan E.; Turner, Megan; Carriquiry, Gabriela et al. (2015). Temporal Trends in Age at HIV Diagnosis in Cohorts in the United States, the Caribbean, and Central and South America. AIDS and Behavior, 19 (9), S. 1599–1608. http://doi.org/10.1007/s10461-014-0974-x.
Hamilton, Carol D.; Swaminathan, Soumya; Christopher, Devasahayam J.; Ellner, Jerrold; Gupta, Amita et al. (2015). RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61Suppl 3 (suppl 3), S. S155-9. http://doi.org/10.1093/cid/civ611.
Cesar, Carina; Jenkins, Cathy A.; Shepherd, Bryan E.; Padgett, Denis; Mejía, Fernando et al. (2015). Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study. The Lancet. HIV, 2 (11), S. e492-500. http://doi.org/10.1016/S2352-3018(15)00183-6.
Castilho, Jessica L.; Luz, Paula M.; Shepherd, Bryan E.; Turner, Megan; Ribeiro, Sayonara R. et al. (2015). HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts. Infectious Agents and Cancer, 10 (1), S. 4–4. http://doi.org/10.1186/1750-9378-10-4.
Carriquiry, Gabriela; Fink, Valeria; Koethe, John Robert; Giganti, Mark Joseph; Jayathilake, Karu et al. (2015). Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. Journal of the International AIDS Society, 18, S. 20016–20016. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26165322
Duda, Stephany N.; McGowan, Catherine C. & Gadd, Cynthia S. (2015). Perceived Reasons for High and Low Quality Observational HIV Research Data. Studies in Health Technology and Informatics, 216, S. 994–994. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26262296
Marcelin, A.; Perodin, C.; Baja, C.; Bright, A.; Duperval, J. et al. (2015). Developing an Electronic Medical Record for Interlinked Care Services in Haiti. Studies in Health Technology and Informatics, 216, S. 883–883. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26262185
2014
IeDEA and ART Cohort Collaborations, Matthias; Avila, Dorita; Althoff, Keri N.; Mugglin, Catrina; Wools-Kaloustian, Kara et al. (2014). Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. Journal of Acquired Immune Deficiency Syndromes (1999), 65 (1), S. e8-16. http://doi.org/10.1097/QAI.0b013e3182a39979.
Cesar, Carina; Shepherd, Bryan E.; Jenkins, Cathy A.; Ghidinelli, Massimo; Castro, Jose Luis et al. (2014). Use of third line antiretroviral therapy in Latin America. PloS One, 9 (9), S. e106887–e106887. http://doi.org/10.1371/journal.pone.0106887.
Ballif, M.; Nhandu, V.; Wood, R.; Dusingize, J. C.; Carter, E. J. et al. (2014). Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 18 (11), S. 1327–36. http://doi.org/10.5588/ijtld.14.0106.
Duda, Stephany N.; Farr, Amanda M.; Lindegren, Mary Lou; Blevins, Meridith; Wester, C. William et al. (2014). Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaborati. Journal of the International AIDS Society, 17 (1), S. 19045–19045. http://doi.org/10.7448/IAS.17.1.19045.
2013
Cortes, Claudia P.; Wehbe, Firas H.; McGowan, Catherine C.; Shepherd, Bryan E.; Duda, Stephany N. et al. (2013). Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis. PloS One, 8 (9), S. e74057–e74057. http://doi.org/10.1371/journal.pone.0074057.
Fenner, Lukas; Ballif, Marie; Graber, Claire; Nhandu, Venerandah; Dusingize, Jean Claude et al. (2013). Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. PloS One, 8 (10), S. e77697–e77697. http://doi.org/10.1371/journal.pone.0077697.
2012
Zhou, Jialun; Jaquet, Antoine; Bissagnene, Emmanuel; Musick, Beverly; Wools-Kaloustian, Kara et al. (2012). Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. Journal of the International AIDS Society, 15 (1), S. 5. http://doi.org/10.1186/1758-2652-15-5.
Duda, Stephany N.; Shepherd, Bryan E.; Gadd, Cynthia S.; Masys, Daniel R. & McGowan, Catherine C. (2012). Measuring the quality of observational study data in an international HIV research network. PloS One, 7 (4), S. e33908–e33908. http://doi.org/10.1371/journal.pone.0033908.
Shepherd, Bryan E.; Shaw, Pamela A. & Dodd, Lori E. (2012). Using audit information to adjust parameter estimates for data errors in clinical trials. Clinical Trials (London, England), 9 (6), S. 721–729. http://doi.org/10.1177/1740774512450100.
Yiannoutsos, Constantin Theodore; Johnson, Leigh Francis; Boulle, Andrew; Musick, Beverly Sue; Gsponer, Thomas et al. (2012). Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sexually Transmitted Infections, 88 Suppl 2 (Suppl 2), S. i33-43. http://doi.org/10.1136/sextrans-2012-050658.
2011
Fink, Valeria I.; Shepherd, Bryan E.; Cesar, Carina; Krolewiecki, Alejandro; Wehbe, Firas et al. (2011). Cancer in HIV-Infected Persons From the Caribbean, Central and South America. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56 (5), S. 467–473. http://doi.org/10.1097/QAI.0b013e31820bb1c3.
Crabtree-Ramírez, Brenda; Caro-Vega, Yanink; Shepherd, Bryan E.; Wehbe, Firas; Cesar, Carina et al. (2011). Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PloS One, 6 (5), S. e20272–e20272. http://doi.org/10.1371/journal.pone.0020272.
Hoyo-Ulloa, Irma; Belaunzarán-Zamudio, Pablo F.; Crabtree-Ramirez, Brenda; Galindo-Fraga, Arturo; Pérez-Aguinaga, María Eugenia et al. (2011). Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 15 (6), S. e408-14. http://doi.org/10.1016/j.ijid.2011.02.007.
Shepherd, Bryan E. & Yu, Chang (2011). Accounting for Data Errors Discovered from an Audit in Multiple Linear Regression. Biometrics, 67 (3), S. 1083–1091. http://doi.org/10.1111/j.1541-0420.2010.01543.x.
Chi, Benjamin H.; Yiannoutsos, Constantin T.; Westfall, Andrew O.; Newman, Jamie E.; Zhou, Jialun et al. (2011). Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America. PLoS Medicine, 8 (10), S. e1001111. http://doi.org/10.1371/journal.pmed.1001111.
2010
Tuboi, Suely Hiromi; Pacheco, Antonio Guilherme; Harrison, Lee H.; Stone, Roslyn A.; May, Margaret et al. (2010). Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes, 53 (1), S. 70–77. http://doi.org/10.1097/QAI.0b013e3181c22d19.
Cesar, Carina; Shepherd, Bryan E.; Krolewiecki, Alejandro J.; Fink, Valeria I.; Schechter, Mauro et al. (2010). Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America. PLoS ONE, 5 (6), S. e10490–e10490. http://doi.org/10.1371/journal.pone.0010490.
Duda, Stephany N.; Wehbe, Firas H. & Gadd, Cynthia S. (2010). Desiderata for a computer-assisted audit tool for clinical data source verification audits. Studies in Health Technology and Informatics, 160 (Pt 2), S. 894–898. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20841814
2009
Tuboi, Suely H.; Schechter, Mauro; McGowan, Catherine C.; Cesar, Carina; Krolewiecki, Alejandro et al. (2009). Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean. JAIDS Journal of Acquired Immune Deficiency Syndromes, 51 (5), S. 615–623. http://doi.org/10.1097/QAI.0b013e3181a44f0a.
Dorjgochoo, Tsogzolmaa; Noel, Francine; Deschamps, Marie Marcelle; Theodore, Harry; Dupont, William et al. (2009). Risk Factors for HIV Infection Among Haitian Adolescents and Young Adults Seeking Counseling and Testing in Port-au-Prince. JAIDS Journal of Acquired Immune Deficiency Syndromes, 52 (4), S. 498–508. http://doi.org/10.1097/QAI.0b013e3181ac12a8.
2008
Pacheco, A. G.; Saraceni, V.; Tuboi, S. H.; Moulton, L. H.; Chaisson, R. E. et al. (2008). Validation of a Hierarchical Deterministic Record-Linkage Algorithm Using Data From 2 Different Cohorts of Human Immunodeficiency Virus-Infected Persons and Mortality Databases in Brazil. American Journal of Epidemiology, 168 (11), S. 1326–1332. http://doi.org/10.1093/aje/kwn249.
Noel, Francine; Mehta, Sapna; Zhu, Yuwei; Rouzier, Patricia De Matteis; Marcelin, Abdias et al. (2008). Improving Outcomes in Infants of HIV-Infected Women in a Developing Country Setting. PLoS ONE, 3 (11), S. e3723–e3723. http://doi.org/10.1371/journal.pone.0003723.
2007
McGowan, Catherine C.; Cahn, Pedro; Gotuzzo, Eduardo; Padgett, Denis; Pape, Jean W. et al. (2007). Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. International Journal of Epidemiology, 36 (5), S. 969–976. http://doi.org/10.1093/ije/dym073.
Duda, Stephany N.; Cushman, Clint & Masys, Daniel R. (2007). An XML model of an enhanced data dictionary to facilitate the exchange of pre-existing clinical research data in international studies. Studies in Health Technology and Informatics, 129 (Pt 1), S. 449–453.